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ABSTRACT 
 
Living organisms perform chemical reactions in order to survive and 
to maintain functions from reproduction to cell growth. Their 
exposure to continuous changes in the environment and competitive 
pressure impose a requirement for rapid adjustment. These adaptive 
responses may include reduction of growth upon deprivation of a 
sugar source or minimization of damaging effects upon thermal 
stress. This PhD thesis includes the structural characterization of two 
enzymes, which respond to environmental changes.  
The first protein studied within the scope of the PhD work is the 
bifunctional enzyme CTP:L-myo-inositol 1-phosphate 
cytidylyltransferase (IPCT) and CDP-L-myo-inositol myo-
inositolphosphotransferase (DIPPS) from Archaeoglobus fulgidus. A. 
fulgidus is a hyperthermophilic archaeon with an optimum growth 
temperature around 83˚C. IPCT/DIPPS is involved in the synthesis of 
a compatible solute (di-myo-inositol-1,3´-phosphate), assumed to 
confer thermostability to cellular components and has only been 
found in (hyper)thermophilic organisms (Borges et al., 2010). It 
comprises two domains: a cytoplasmic N-terminal domain (IPCT) 
homologous to nucleotidyltransferases and a membrane C-terminal 
domain (DIPPS) that belongs to the CDP-alcohol 
phosphatidyltransferase family. 
IPCT/DIPPS was heterologously overexpressed in Escherichia coli, 
solubilized with detergent, and successfully purified by immobilized 
VIII 
 
metal ion affinity chromatography. The 55 kDa protein was 
crystallized using either the vapor diffusion method or in lipidic 
mesophases. The mesophases approach yielded better quality crystals 
(best diffraction around 2.8 Å resolution at synchrotron sources) 
compared to the more traditional vapor diffusion method (diffraction 
ca. 4.5 Å). The IPCT/DIPPS structure was solved by molecular 
replacement using the X-ray structure of IPCT previously determined 
by Brito et al. (2012) and further completed by iterative cycles of 
model building and refinement. The structure reveals that the DIPPS 
domain consists mainly of 6 transmembrane helices and a helix 
connector to the IPCT domain, which binds weakly to the solvent 
exposed edge of the DIPPS domain. The crystal structure of 
IPCT/DIPPS is arranged as a dimer, with an interface formed by three 
transmembrane helices from each chain. A metal binding site is 
present in the DIPPS domain, where a putative magnesium ion is 
surrounded by 4 aspartate residues, 3 of which belong to the 
consensus sequence of CDP-alcohol phosphatidyltransferase family. 
Moreover, the substrate L-myo-inositol 1-phosphate was modeled 
into the catalytic site of the DIPPS domain. Mutagenesis studies 
allowed identification of several residues essential for DIPPS activity. 
Because CDP-myo-inositol, the product of IPCT activity, is a substrate 
of DIPPS, the arrangement of both domains in the X-ray structure is 
somewhat surprising, as their active sites are not facing each other. 
Interestingly, in most organisms IPCT and DIPPS are present as a 
single gene product, although separate genes are also found in 
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several other organisms (Gonçalves et al., 2012). It is yet unclear 
whether cooperation exists between the domains harboring these two 
consecutive activities. At present, it is also not known whether 
conformational changes occur upon ligand binding at the IPCT 
domain, which could eventually bring it into a more favorable 
orientation towards the active site of DIPPS.  
DIPPS is a member of the CDP-alcohol phosphatidyltransferase class 
I family, for which no structure was yet available. This family 
comprises integral membrane proteins, such as choline/ethanolamine 
phosphotransferase and cardiolipin synthase. Members of this family 
are present in all domains of life and usually involved in 
phospholipid biosynthesis. The three-dimensional structure of 
IPCT/DIPPS determined at 2.8 Å resolution will have a very 
significant impact in the field of lipid biosynthesis and will certainly 
pave the way to other studies, e.g. mechanism of reactions, homology 
modeling followed by structure-based drug design. 
The second enzyme described in this thesis is α-phosphoglucomutase 
from Lactococcus lactis (APGM). This enzyme plays an important role 
in carbohydrate metabolism by catalyzing the reversible conversion 
of α-glucose 1-phosphate to glucose 6-phosphate. 
Phosphoglucomutase is widespread in living organisms from bacteria 
to humans. It mediates utilization of phosphoglucose either for 
biosynthesis or, upon sugar source deprivation, for glycolysis. Thus, 
this enzyme is a crucial link between catabolic and anabolic processes 
(Neves et al., 2006).  
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The 30 kDa APGM was overexpressed in Lactococcus lactis and 
purified by immobilized metal ion affinity chromatography. It was 
crystallized by vapor diffusion method and X-ray diffraction data 
were collected at synchrotron source to 1.5 Å resolution. APGM 
structure was determined by single wavelength anomalous 
dispersion using a crystal soaked with a platinum compound. APGM 
structure shows that the most similar known structures are not the 
common bacterial α-phosphoglucomutases that belong to 
phosphohexomutase superfamily, but the eukaryotic 
phosphomannomutases (PMMs), though APGM is not able to utilize 
phosphomannose. APGM and PMMs belong to the haloacid 
dehalogenase superfamily (HADSF) and APGM is the first member 
of this superfamily with strict specificity for α-glucose 1-phosphate. 
APGM is present as a dimer in both the crystal structure and in 
solution, an arrangement that may be functionally relevant; however 
the dimer interface differs from that found in eukaryotic PMMs. 
Structural superposition of APGM and PMMs highlights their 
similarity and differences. Like other members of HADSF, APGM 
comprises two domains, the cap and core, which open to bind 
substrate and then close to provide a solvent-exclusive environment 
for catalysis (Silvaggi et al., 2006). Interestingly, the cap domain in 
APGM structure is found in a tightly closed conformation in 
comparison with other eukaryotic PMMs. Although we could not 
obtain the structure of APGM with ligands to assess the 
conformational changes induced upon their binding, in the APGM 
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crystal structure a sulfate and a glycerol were found at the enzyme 
active site. Both of these molecules partially mimic the substrate, 
which together with structural comparisons with other PMMs and 
docking studies provided insights into both the catalytic mechanism 
and the strict substrate selectivity of APGM. 
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RESUMO 
 
As reacções químicas são essenciais para a sobrevivência dos 
organismos vivos e manutenção de inúmeras funções, desde a 
reprodução ao crescimento celular. A exposição destes organismos a 
mudanças contínuas no ambiente exercem uma pressão selectiva para 
uma rápida adaptação, que pode envolver a redução do crescimento 
face à privação da fonte de açúcar ou a minimização dos efeitos 
prejudiciais causados pelo stress térmico. Esta tese de doutoramento 
inclui a caracterização estrutural de duas enzimas envolvidas na 
resposta a alterações ambientais.    
A primeira proteína  de estudo no âmbito do trabalho de 
doutoramento é a enzima bifuncional citidililtransferase de L-myo-
inositol 1-fosfato (IPCT) e fosfotransferase de CDP-L-myo-inositol:L-
myo-inositol 1-fosfato (DIPPS) de Archaeoglobus fulgidus.  A. fulgidus é 
um arqueão hipertermofílico com temperatura óptima de crescimento 
à volta de 83˚C. A IPCT/DIPPS está envolvida na síntese de um soluto 
compatível (1,3´-di-myo-inositol-fosfato, DIP), que confere 
termoestabilidade aos componentes celulares dos organismos e só 
ainda foi possível encontrar esta enzima em (hiper)termófilos (Borges 
e al., 2010). A IPCT/DIPPS contém dois domínios: o N-terminal 
citoplasmático (IPCT) homólogo de nucleotidiltransferases e o C-
terminal membranar (DIPPS) que pertence à família de 
fosfatidiltransferase de CDP-álcool. 
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A enzima IPCT/DIPPS foi sobre-expressa heterologamente em 
Escherichia coli, solubilizada com detergente e purificada com sucesso 
por cromatografia  de afinidade do ião metálico imobilizado. A 
proteína de 55 kDa foi cristalizada usando o método da difusão do 
vapor ou em mesofases lipídicas. A técnica das mesofases provou ser 
mais adequada para o crescimento de cristais de melhor qualidade (a 
melhor diffracção obtida foi cerca de 2.8 Å em sinctrotrão) comparada 
com o método mais tradicional da difusão do vapor (diffracção 
aproximada de 4.5 Å). A estrutura de IPCT/DIPPS foi resolvida pelo 
método da substituição molecular, usando a estrutura de raios-X da 
IPCT determinada por Brito e al. (2012). De seguida, foram  realizados 
ciclos iterativos de construção do modelo e refinamento 
cristalográfico. A estrutura revela que o domínio DIPPS é constituído 
essencialmente por seis hélices transmembranares e uma hélice 
conectora ao domínio IPCT, que liga fracamente à zona exposta ao 
solvente do domínio DIPPS. A estrutura cristalina de IPCT/DIPPS 
forma um dímero, sendo a sua interface composta por três hélices 
transmembranares de cada cadeia polipeptídica. No domínio DIPPS 
encontra-se um local de ligação a um metal, onde existe um magnésio 
putativo, rodeado por 4 aspartatos, 3 dos quais pertencem à 
sequência de consenso da família fosfatidiltransferase de CDP-álcool. 
O substrato L-myo-inositol 1-fosfato, foi modelado no centro activo do 
domínio DIPPS. Ensaios de mutagénese permitiram identificar 
diversos amino ácidos essenciais para a actividade catalítica da 
DIPPS. Sendo o produto da reacção da IPCT (CDP-L-myo-inositol) 
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substrato da DIPPS, o arranjo de ambos os domínios na estrutura 
cristalina não deixa de ser de algum modo surpreendente, dado que 
os seus centros activos não estão orientados um para o outro. É 
interessante notar que na maioria dos organismos,  um único gene 
codifica para a proteína bifuncional IPCT/DIPPS, embora existam 
alguns organismos, onde os genes se encontram separados 
(Gonçalves et al., 2012). Não é contudo evidente se existe cooperação 
entre os domínios que abrigam estas duas actividades consecutivas. 
De momento, também não se sabe se ocorrem alterações 
conformacionais aquando da ligação do ligando ao domínio IPCT, 
que poderia eventualmente posicioná-lo numa orientação mais 
favorável relativamente ao centro catalítico da DIPPS.  
A DIPPS é membro da família da classe I de fosfatidiltransferase de 
CDP-álcool, para a qual ainda não havia nenhuma estrutura 
caracterizada. Esta família inclui proteínas membranares integrais, 
tais como fosfotransferase de colina/etanolamina e  sintase da 
cardiolipina. Os membros desta família estão presentes em todos os 
domínios da vida e encontram-se geralmente envolvidos na biosínese 
de fosfolípidos. A estrutura tri-dimensional da IPCT/DIPPS 
determinada a 2.8 Å de resolução terá um impacto muito significativo 
no campo da biosíntese de lípidos e irá certamente abrir portas a 
outros estudos, tais como, mecanismos das reacções, modelação 
molecular por homologia e desenvolvimento de fármacos baseado  na 
estrutura (rational drug design). 
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A segunda enzima descrita nesta tese é α-fosfoglucomutase de Lactis 
de Lactococcus (APGM). Esta enzima desempenha um papel 
importante no metabolism dos hidrato de carbono catalisando a 
conversão reversível da α-glucose 1-fosfato a glucose 6-fosfato. A 
fosfoglucomutase está presente nos organismos vivos, das bactérias 
aos seres humanos. A APGM medeia a utilização da fosfoglucose 
para o biosíntese ou, em caso de privação da fonte do açúcar, para a 
glicólise. Assim, esta enzima faz a ligação entre os processos 
catabólicos e anabólicos (Neves et al., 2006).  
A APGM (~30 kDa) foi sobre-expressa em Lactococcus lactis e 
purificada por cromatografia  de afinidade do ião metálico 
imobilizado. Foi cristalizada pelo método da difusão do vapor e os 
dados de diffracção de raios-X foram recolhidos em instalações de 
sincrotrão a 1.5 Å de resolução. A estrutura da APGM foi 
determinada pelo método da dispersão anómala com um único 
comprimento de onda usando um cristal derivatizado com um 
composto de platina (Pt).  A estrutura da APGM mostra que as 
estruturas que lhe são mais homólogas não são as α-
fosfoglucomutases bacterianas que pertencem à superfamília das 
fosfohexomutases mas as fosfomanomutases eucarióticas (PMMs), 
embora a APGM não possa utilizar a fosfomanose como substrato. 
APGM e PMMs pertencem à superfamília haloacid dehalogenase 
(HADSF) e a APGM é o primeiro membro desta superfamília com 
estrita especificidade para a α-glucose 1-fosfato. A APGM encontra-se 
na forma dimérica na estrutura cristalina e em solução, arranjo este 
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que pode ser funcionalmente relevante. No entanto, a interface do 
dímero na APGM difere daquela encontrada nas PMMs eucarióticas. 
A sobreposição estrutural da APGM e das PMMs destaca as suas 
semelhanças e diferenças. Tal como os outros membros da HADSF, a 
APGM contém dois domínios, a tampa e o núcleo, que abrem para 
possibilitar a ligação do substrato e depois fecham, providenciando 
um ambiente favorável à catálise com exclusão de solvente (Silvaggi 
et al., 2006). O domínio da tampa da estrutura da APGM encontra-se 
numa conformação mais fechada em comparação com as restantes 
estruturas das PMMs. Embora não tenha sido possível obter a 
estrutura da APGM com ligandos para caracterizar as alterações 
conformacionais induzidas pelos mesmos, um sulfato e um glicerol 
estão presentes no centro activo da enzima. Ambas estas moléculas 
mimetizam parcialmente o substrato, e em conjunto com análise 
estrutural de outras PMMs e estudos de modelação fornecem  dados 
importantes para uma melhor compreensão do mecanismo catalítico 
e da estrita selectividade da APGM. 
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ABBREVIATIONS 
 
α-PGM α-phosphoglucomutase 
APGM  α-phosphoglucomutase from Lactococcus lactis 
ATP  adenosine triphosphates 
β-PGM β–phosphoglucomutase 
BLAST basic local alignment search tool 
CMP  cytidine monophosphate 
CTP/CDP cytidine triphosphate/diphosphate 
CDP-OH_P_trans CDP-alcohol phosphatidyltransferase family 
CMC  critical micelle concentration 
CSP  consensus sequence pattern of the CDP-OH_P_trans 
CSS  complex formation significance score (in PISA server) 
Cymal-5  5-cyclohexyl-1-pentyl-β-D-maltoside 
DAG  diacylglycerol 
DDM  n-dodecyl-β-D-maltoside 
DIPPS  CDP-L-myo-inositol myo-inositolphosphotransferase 
DIPP  di-myo-inositol-1,3´-phosphate-1´-phosphate 
DIP  di-myo-inositol-1,3´-phosphate 
DNA  deoxyribonucleic acid 
EDTA  ethylenediaminetetraacetic acid 
GDP  guanosine diphosphate 
GPI  glycero-phospho-myo-inositol 
HAD  haloacid dehalogenases 
HADSF  haloacid dehalogenase superfamily 
IPCT  CTP:L-myo-inositol 1-phosphate cytidylyltransferase 
IPTG  isopropyl-β-D-thiogalactopyranoside 
LB  Luria Bertani culture media 
NCS  non-crystallographic symmetry 
NMR  nuclear magnetic resonance spectroscopy 
OD  optical density 
OG  n-octyl-β-D-glucoside 
PCR  polymerase chain reaction 
PDB  protein data bank 
PGP  phosphatidylglycerophosphate 
PMM  eukaryotic phosphomannomutases 
PMSF phenylmethanesulfonylfluoride 
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rmsd root-mean-square deviation 
rpm revolutions per minute 
SAD single-wavelength anomalous diffraction 
SDS-PAGE sodium dodecyl sulphate polyacrylamide gel 
electrophoresis 
SEC size-exclusion chromatography 
TB terrific broth culture media  
TCEP tris(2-carboxyethyl)phosphine 
TLS translation libration screw-motion (method of 
structure refinement) 
TM  transmembrane helix 
Triton X-100 nonaethylene glycol octylphenol ether  
UDP/UTP uridine diphosphate/triphosphate 
v/v  volume by volume 
WT  wild-type enzyme 
w/v  weight by volume 
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Chapter 1 
1.1 HALOACID DEHALOGENASE SUPERFAMILIY 
OF ENZYMES IN PHOSPHOTRANSFER 
REACTIONS 
 
1.1.1 HAD SUPERFAMILIY 
Haloacid dehalogenase (HAD) superfamily (CL0137), includes a 
diverse range of enzymes that use an aspartate carboxylate as 
nucleophile (Aravind et al., 1998; Koonin and Tatusov, 1994). There 
are ~79000 sequences classified into this superfamily in Pfam 
database and even more sequences, 148000, classified as HAD-like in 
the UniProt database (as of 19th February 2013). Members of this 
family are found in all domains of life and catalyze a variety of 
reactions with hydrolases being predominant in the superfamily 
(Figure 1.1), including the phosphoesterases, ATPases, 
phosphonatases, dehalogenases and sugar phosphomutases, which 
utilize a variety of different substrates (Burroughs et al., 2006). HAD 
superfamily is divided into 21 Pfam families, of which 13 are also 
represented in the InterPro database (Table 1.1). 
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Figure 1.1 Taxonomy (top) and enzyme classes (bottom) of the haloacid 
dehalogenase superfamily sequences classified in UniProtKB. The enzyme classes: 
EC 3.3.2.3 - epoxide hydrolase, EC 3.6.1.35 - H+-exporting ATPase, EC 3.6.1.36 - 
H+/K+-exchanging ATPase, EC 3.6.1.37 - Na+/K+-exchanging ATPase, EC 3.6.1.38 - 
Ca2+-transporting ATPase, EC 3.6.3.13 - aminophospholipid-transporting ATPase, 
EC 1.7.3.4 - hydroxylamine oxidase, EC 2.1.1.36 - TRNA (adenine-N1-)-
methyltransferase. 
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Table 1.1 Enzyme families classified into HAD in the Pfam and InterPro 
databases. The number of sequences refers to Pfam database on 13/03/2013. 
Abbreviation Description Pfam Sequences InterPro 
HAD_2 Haloacid dehalogenase-
like hydrolase 
PF13419 22576  
hydrolase Haloacid dehalogenase-
like hydrolase 
PF00702 18348 IPR005834 
hydrolase_3 haloacid dehalogenase-
like hydrolase 
PF08282 13347 IPR013200 
HAD haloacid dehalogenase-
like hydrolase 
PF12710 6179  
hydrolase_like HAD-hydrolase-like PF13242 5583  
hydrolase_6 Haloacid dehalogenase-
like hydrolase 
PF13344 3060  
NIF NLI interacting factor-
like phosphatase 
PF03031 2044  
trehalose_PPase Trehalose-phosphatase PF02358 1750 IPR003337 
hydrolase_like2 Putative hydrolase of 
sodium-potassium 
ATPase alpha subunit 
PF13246 1296  
acid_phosphat_B HAD superfamily, 
subfamily IIIB, acid 
phosphatase 
PF03767 1117 IPR005519 
PNK3P Polynucleotide kinase 3 
phosphatase 
PF08645 685 IPR013954 
S6PP Sucrose-6F-phosphate 
phosphohydrolase 
PF05116 588 IPR006380 
PMM Eukaryotic 
phosphomannomutase 
PF03332 465 IPR005002 
NT5C 5' nucleotidase, 
deoxy(Pyrimidine), 
cytosolic type C protein 
PF06941 458 IPR010708 
LNS2 Lipin/Ned1/Smp2 PF08235 430 IPR013209 
5_nucleotid 5' nucleotidase family PF05761 371 IPR008380 
PGP_phosphatase Mitochondrial PGP 
phosphatase 
PF09419 250 IPR010021 
Acid_PPase Acid phosphatase PF12689 225  
Put_phosphatase Putative phosphatase PF06888 213 IPR006384 
UMPH-1 Pyrimidine 5'-
nucleotidase 
PF05822 159  
DUF705 Protein of unknown 
function 
PF05152 68 IPR007827 
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RANGE OF ARCHITECTURES 
Structural characterization of proteins from the HAD superfamily 
resulted in over 400 entries in the Protein Data Bank (PDB) as 
indicated in the Pfam database. Members of this superfamily 
comprise a characteristic HAD domain with a Rossmannoid fold and 
with a catalytic aspartate located at the end of the first β-strand of the 
central core β-sheet (Burroughs et al., 2006). The structural element 
characteristic of this domain includes an almost completed one helical 
turn, just after the first β-strand and followed by a β-hairpin turn 
(Figure 1.2).  
 
 
Figure 1.2 Topology diagram of the HAD domain. Indicated are insertions of the 
C0/C1 and C2 structural classes. In pink is shown the characteristic nearly 
completed helical turn and in green the β-hairpin. This figure is taken from (Allen 
and Dunaway-Mariano, 2009).  
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HAD domain (core domain) provides a catalytic scaffold for reactions 
with conserved amino acid residues, including the catalytic aspartate 
that is transiently phosphorylated in the phosphotransfer enzymes, 
and the residues binding magnesium ion (Allen and Dunaway-
Mariano, 2009). 
The adaptation to a wide range of functions and substrates in the 
HAD superfamily enzymes is enabled by additional insertions into 
the conserved HAD domain (Figure 1.2). Based on the topology of 
insertion and its position, the superfamily can be divided into 
structural classes C0, C1, C2 (Allen and Dunaway-Mariano, 2009; 
Burroughs et al., 2006).  
The C0 class contains the shortest insert and thus can be considered 
as the most basic member of HAD superfamily. This class contains 
mainly phosphatases showing different degrees of elaboration 
concerning the insert in the β-hairpin turn; none in deoxy-D-
mannose-octulosonate 8-phosphate phosphatase (e.g. PDB code: 1j8d) 
to one additional β-strand in CTD phosphatases (e.g. PDB code: 
3pgl). 
The C1 class contains a larger insert in the characteristic β-hairpin 
(Figure 1.2), which folds into a cap domain separated from the HAD 
domain (core domain). The cap domains in this class may be only α-
helical as in β-phosphoglucomutases (e.g. PDB code: 1lvh) or show 
α+β fold, as P-type ATPases (e.g. PDB code: 1t5t). 
The C2 class possesses a cap domain inserted into the loop after β3-
strand. Caps of this class are α+β and two major types can be 
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distinguished. One resembles the cap of Cof-type phosphatases and 
the second resembles the cap of NagD-like phosphatases. The Cof-
type phosphatases contain a central three stranded antiparallel β-
sheet (PDB code: 1l6r), which can be extended by a number of 
additional secondary structure elements (PDB code: 1xvi). Moreover, 
in the NagD-like phosphatases, the basic structural element of the cap 
domain consists of four-stranded parallel β-sheet, along with one N-
terminal antiparallel strand; the  β-hairpin is positioned after the 
third strand and this fold can be observed in 4-
nitrophenylphosphatase (PDB code: 1VJR).  
 
CATALYTIC MECHANISM OF PHOSPHOTRANSFER 
The common core domain of the HAD superfamily provides the 
conserved catalytic residues and shows similar reaction mechanisms 
(Figure 1.3). This is particularly evident in the case of 
phosphotransferases, as they all utilize a strictly conserved aspartate 
as a nucleophile forming an intermediate aspartylphosphate. In the 
subsequent stage, depending on the type of reaction, the intermediate 
is either hydrolyzed as in phosphatases or phosphoryl is transferred 
to a hydroxyl group, as in phosphohexomutases (Figure 1.3). 
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Figure 1.3 Reaction mechanisms utilized within the HAD superfamily. This figure 
is taken from Burroughs et al., 2006. 
 
Besides the nucleophilic aspartate sited in loop 1 and coordinated to 
Mg2+, there is a number of other residues located in the catalytic site 
of the core domain, which are conserved (Figure 1.4). In loop 1 
following the first β-strand and positioned two residues after the 
nucleophilic Asp, is another aspartate with acid/base function. It 
protonates the leaving group in the first stage of the reaction and acts 
as proton acceptor in the final stage of phosphoryl transfer from 
aspartylphosphate. 
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Figure 1.4 Schematic representation of the HAD catalytic scaffold with indicated 
interactions between phosphoester substrate and conserved residues. This figure 
is taken from Dai et al., 2009.  
 
In phosphotransferases, the metal ion is coordinated to three 
negatively charged Asp/Glu residues and the phosphoryl group of 
the substrate, thus playing a role in their electrostatic stabilization 
and probably also stabilizing the transition state by neutralizing its 
charge (Allen and Dunaway-Mariano, 2009). 
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1.1.2 EUKARYOTIC PHOSPHOMANNOMUTASES AND  
β-PHOPHOGLUCOMUTASES 
 
Eukaryotic phosphomannomutases (PMM, IPR005002) resemble the 
architecture of Cof-type phosphatase of the C2 class of HAD 
superfamily (Figure 1.5a). These enzymes are involved in the 
reversible interconversion of mannose 6-phosphate and mannose 1-
phosphate, which is required in the synthesis of GDP-mannose 
needed in the glycosylation of human proteins (Schollen et al., 1998; 
Tomavo et al., 1992). Moreover, PMMs also catalyze the 
interconversion of glucose 1-phosphate to glucose 6-phosphate 
(Silvaggi et al., 2006).  
The two interconversion reactions of PMMs can also be catalyzed by 
unrelated enzymes, members of different α-D-phosphohexomutase 
superfamily widely found in bacteria and in other domains of life. 
However, as shown in the Figure 1.5c, the protein topology of α-D-
phosphohexomutases is quite different from the HAD superfamily 
(Figure 1.5a-b). In addition, the α-D-phosphohexomutase superfamily 
utilizes serine as active site residue involved in phosphorylation, thus 
the reaction mechanism is also distinct from the eukaryotic 
phosphomannomutases (Shackelford et al., 2004).  
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Figure 1.5 Representation of different folds of HAD superfamily members: (a) the 
human phosphomannomutase 1 (PDB code: 2fue), (b) β-phosphoglucomutase from 
Lactococcus lactis (PDB code: 1lvh); and α-D-phosphohexomutase superfamily 
member: (c) phosphomannomutase/phosphoglucomutase from Pseudomonas 
aeruginosa (PDB code: 2h4l). Figure drawn with CCP4MG (McNicholas et al., 
2011). 
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HAD superfamily also includes another enzyme, β-
phosphoglucomutase, which catalyzes the reversible conversion of a 
different phosphoglucose anomer, β-glucose 1-phosphate to β-
glucose 6-phosphate. Interestingly, the recognition of this anomeric 
substrate was achieved with a very different topology of the cap 
domain from the one of eukaryotic phosphomannomutases (Figure 
1.5b). The cap insertion into the β-hairpin following the first β-strand 
categorizes the β-phosphoglucomutase into the class C1 of the HAD 
superfamily.  
Eukaryotic PMMs share with β-phosphoglucomutases the 
requirement for an activator of the reaction, respectively α or β 
anomer of glucose-1,6-bisphosphate (also α-mannose-1,6-
bisphosphate in PMMs) (Silvaggi et al., 2006; Zhang et al., 2005). 
These activators are utilized to phosphorylate the nucleophile Asp 
yielding an active enzyme, which in further cycles utilize 
monophosphorylated substrates (Figure 1.6). For the well studied β-
phosphoglucomutase from Lactococcus lactis (Griffin et al., 2012; 
Lahiri et al., 2002; Zhang et al., 2005) phosphoryl transfer was 
proposed from aspartyl of the activated enzyme to the substrate 
forming an intermediate β-glucose-1,6-bisphosphate intermediate. 
This intermediate needs to be rearranged, likely by its release from 
the active site followed by recapturing in a different position with the 
phosphoryl of the substrate to be removed located next to the 
nucleophile Asp. In the final stage of the reaction the active form of 
the enzyme with aspartylphosphate is regenerated and the product 
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released. It is also suggested that when the reaction takes place the 
cap domain closes tightly over the core domain to exclude the solvent 
from the active site and prevent transfer of the phosphoryl to water 
molecule (Dai et al., 2009). However, for the release and rebinding of 
the intermediate in the rearranged position, the cap needs to open, 
since the space available in the active site is not sufficient for the flip 
to take place. Similar mechanism was also suggested for human 
PMM 1 (Silvaggi et al., 2006).  
 
 
Figure 1.6 Catalytic cycling in β-phosphoglucomutase from Lactococcus lactis. 
This figure is taken from Dai et al., 2009. 
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1.1.3 α-PHOSPHOGLUCOMUTASE FROM LACTOCOCCUS 
LACTIS 
 
Bacterial α-phosphoglucomutases studied so far belong to the α-D-
phosphohexomutase superfamily. In 2006, Neves et al. identified and 
characterized a gene of a bacterial α-phosphoglucomutase, which 
was unrelated to α-D-phosphohexomutase superfamily (Neves et al., 
2006). This gene of Lactococcus lactis with UniProt accession number 
Q00G41 encodes for a protein with 252 amino acids. In fact 
Lactococcus lactis does not possess a gene commonly found in bacteria 
encoding for a protein of about 400 amino acids with α-
phosphoglucomutase activity of the α-D-phosphohexomutase 
superfamily. Instead, the newly identified gene provides a 
replacement for this.  
Sequence analysis revealed the highest sequence identity to 
characterized eukaryotic phosphomannomutases of about 24% and 
only 10% to β-phosphoglucomutase. Moreover, the conserved motifs 
of the HAD superfamily were also found in the protein sequence, in 
particular the catalytic nucleophile Asp8 and the acid/base Asp10. 
Functional characterization of this enzyme revealed that it does not 
utilize β-glucose 1-phosphate or α-mannose 1-phosphate (Neves et 
al., 2006). However, this lactococcal α-phosphoglucomutase catalyzes 
reversible conversion of α-glucose 1-phosphate to glucose 6-
phosphate. From now on this α-phosphoglucomutase from 
Lactococcus lactis will be abbreviated as APGM. 
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Impact of the APGM gene expression was studied in vivo in 
Lactococcus lactis. It was shown that the expression of this gene was 
needed for viability of Lactococcus lactis. Lowered levels of APGM 
activity were sufficient for cell growth but this was accompanied with 
changes in the cell morphology and cell division (Neves et al., 2006). 
It was therefore concluded that the synthesis of the UDP-glucose, 
precursor for cell wall biosynthesis, relies on APGM activity. 
Moreover, overexpression of APGM in L. lactis grown on galactose 
indicated that this enzyme activity is the bottleneck in galactose 
metabolism. On the other hand, in L. lactis grown on glucose the 
APGM mainly provides substrates for biosynthetic pathways (Neves 
et al., 2006).  
It was shown that similar to other members of the HAD superfamily 
APGM requires presence of Mg2+ for activity. Also α-glucose-1,6-
bisphosphate activator is needed to initiate the catalysis. The reaction 
can proceed into both directions, though the Vmax in the conversion of 
glucose 6-phosphate to α-glucose 1-phosphate is four times lower 
than in the other direction. Also the Km was determined for glucose 6-
phosphate in the millimolar range, while for α-glucose 1-phosphate it 
was 71 µM (Neves et al., 2006). 
The similarities in sequence and activity between lactococcal APGM 
and eukaryotic PMMs raise an obvious question about the structural 
relation between these enzymes. Moreover, the strict specificity of 
APGM towards α-glucose 1-phosphate and not its stereoisomer α-
mannose 1-phosphate like in the case of PMMs points to an 
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interesting subject of substrate specificity, which may rely on some 
subtle structural differences of the enzyme. In order to provide an 
explanation for the observed substrate differentiation we set off to 
determine an atomic model of APGM in this work. The crystallization 
and structure of APGM are described in Chapter 2. 
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1.2 CDP-OH PHOSPHATIDYLTRANSFERASE 
FAMILY & COMPATIBLE SOLUTES 
 
1.2.1 CDP-OH PHOSPHATIDYLINOSITOL TRANSFERASE    
 
CDP-alcohol phosphatidyltransferase family (IPR000462, PF01066) 
comprises enzymes that catalyze the displacement of CMP from a 
CDP-alcohol by a second alcohol with formation of a phosphodiester 
bond and concomitant breaking of a phosphoride anhydride bond. 
The majority of the enzymes characterized so far from this family are 
involved in phospholipids biosynthesis and share a conserved 
sequence pattern DG(x)2AR(x)8G(x)3D(x)3D (PS00379). There are 8035 
sequences classified into the family in the Pfam database and 12756 
sequences in the UniProtKB (as of 3rd February 2013). Members of this 
family are found in all domains of life (Figure 1.7) and are typically 
150 – 400 amino acid residues long. 
Proteins of the CDP-alcohol phosphatidyltransferase (CDP-
OH_P_trans) family are predicted to be located in the membrane. 
Transmembrane helices (TM) prediction performed with TMHMM 
Server v. 2.0 for 106 sequences of the family (the reviewed sequences 
of UniProtKB classified into the family; as on 3rd February 2013) 
indicates two to ten putative transmembrane helices (data not 
shown).  
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Figure 1.7 Taxonomy of the CDP-alcohol phosphatidyltransferase family 
sequences (number of sequences in brackets) classified in UniProtKB.  
 
RANGE OF ACTIVITIES  
The enzymes of CDP-alcohol phosphatidyltransferase family utilize a 
variety of different substrates and the common type of reaction 
involves the general reaction scheme:  
 
CDP–alcohol(1) + alcohol(2)  =  alcohol(1)– P–alcohol(2) + CMP + H+ 
 
However, not all enzymes involved in this type of reaction belong to 
CDP-alcohol phosphatidyltransferase family. A distinct family of 
peripheral membrane proteins, such as phospholipase D, 
phosphatidylserine synthase type (IPR016270, PF00614 or CDP-
alcohol phosphatidyltransferase class-II family in the UniProt 
classification) can replace CDP-alcohol phosphatidyltransferase 
family enzymes in various organisms. 
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Depending on the substrate utilized by the enzyme,  five subfamilies 
of CDP-alcohol phosphatidyltransferase family are already 
differentiated in the InterPro database (Hunter et al., 2012): 
 CDP-diacylglycerol glycerol-3-phosphate 3-phosphatidyltransferase 
(IPR004570) 
 CDP-diacylglycerol serine O-phosphatidyltransferase (IPR004533) 
 CDP-diacylglycerol inositol 3-phosphatidyltransferase (IPR014387) 
 Choline/ethanolamine phosphotransferase (IPR014472) 
 Phosphatidylcholine synthase (IPR026027) 
Another group of enzymes described in this thesis should also be 
included into the family: 
 CDP-L-myo-inositol myo-inositolphosphotransferase classified with 
enzyme entry EC 2.7.8.34 
As it is apparent from the names of the subfamilies, the majority of 
the identified CDP-alcohol phosphatidyltransferase family enzymes 
are involved in phospholipid biosynthesis. Their presence in the 
eukaryotic lipid biosynthetic pathways is indicated in the Figure 1.8. 
There are two routes providing substrates for the lipid biosynthesis 
by CDP-alcohol phosphatidyltransferases and in both of them one of 
the substrates needs to be activated with CDP for reaction (Lykidis, 
2007). In the one initiated by CDP-DAG synthase, the CDP activated 
compound is diacylglycerol and the specific hydrophilic head group 
of the phospholipid is introduced via direct reaction with glycerol-3-
phosphate (phosphatidylglycerol phosphate synthase), inositol 
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(phosphatidylinositol synthase) , serine (phosphatidylserine synthase) 
or phosphatidylglycerol (cardiolipin synthase). The second route 
utilizes diacylglycerol and the hydrophilic head group choline (CDP-
choline:diacylglycerol phosphotransferase) or ethanolamine (CDP-
ethanolamine:diacylglycerol phosphotransferase) is activated with 
CDP for reaction. 
In bacteria, a different route of synthesis of phosphatidylcholine can 
also be found, which involves CDP-diacylglycerol and choline 
(phosphatidylcholine synthase) (Sohlenkamp et al., 2000). In archaea 
a specific type of phosphatidylserine synthase, archaetidylserine 
synthase was identified (Morii and Koga, 2003). This enzyme is 
involved in synthesis of ether lipids, very characteristic for archaea. 
Substrates for the reaction besides serine can be CDP-unsaturated 
archaeol with ether-linked geranylgeranyl chains and CDP-saturated 
archaeol with ether-linked phytanyl chains. 
 
 
 
 
 
22 
  Introduction 
 
Figure 1.8 Lipid biosynthetic pathways in eukaryota. Enzymes belonging to CDP-
alcohol phosphatidyltransferase family are indicated with red box. 
Substrates/products abbreviations: DAG – diacylglycerol, CDP-DAG - CDP-
diacylglycerol, PtdOH - phosphatidic acid, PtdCho - phosphatidylcholine, PtdEtn - 
phosphatidylethanolamine, PtdIns - phosphatidylinositol, PtdSer - 
phosphatidylserine, PtdGro - phosphatidylglycerol, Ptd2Gro - cardiolipin, SM  - 
sphingomyelin, IPC – inositolphosphorylceramide. Enyzme abbreviations: CCT - 
phosphocholine cytidylyltransferase, CDS - CDP-DAG synthase, CK - choline 
kinase, CLS - cardiolipin synthase, CPT - CDP-choline:diacylglycerol 
phosphotransferase, ECT - phosphoethanolamine cytidylyltransferase, EK - 
ethanolamine kinase, EPT - CDP-ethanolamine:diacylglycerol phosphotransferase, 
ICS - inositol phosphorylceramide synthase, PAP - phosphatidate phosphatase, 
PEMT - phosphatidylethanolamine methyltransferase, PEAMT - 
phosphoethanolamine methyltransferase, PIS - phosphatidylinositol synthase, 
PGPP - phosphatidylglycerol phosphate phosphatase, PGS - phosphatidylglycerol 
phosphate synthase, PSS - phosphatidylserine synthase, PSD - phosphatidylserine 
decarboxylase, PSSE - phosphatidylserine synthase via base-exchange, SMS - 
sphingomyelin synthase, SDC - serine decarboxylase. This figure is adapted from 
Lykidis, 2007. 
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However, not all of the CDP-alcohol phosphatidyltransferase 
enzymes are involved in synthesis of lipids. A compatible solute, di-
myo-inositol-1,1´-phosphate (DIP) is found exclusively in 
(hyper)thermophilic archaea and bacteria (Gonçalves et al., 2012). It is 
assumed to confer thermostability to cellular components (Borges et 
al., 2010). DIP synthesis involves CDP-L-myo-inositol myo-
inositolphosphotransferase (DIPPS), a member of the CDP-alcohol 
phosphatidyltransferase family. It utilizes as substrates L-myo-inositol 
1-phosphate and CDP activated L-myo-inositol 1-phosphate. 
Interestingly, it is not the only example of use of L-myo-inositol 1-
phosphate by CDP-alcohol phosphatidyltransferases. It was reported 
that phosphatidylinositol in Mycobacterium tuberculosis was 
synthesized via reaction of CDP-diacylglycerol with L-myo-inositol 1-
phosphate catalyzed by phosphatidylinositol phosphate synthase 
(Morii et al., 2010). 
 
BIOCHEMICAL STUDIES 
The strong hydrophobic character of CDP-alcohol 
phosphatidyltransferases, which are integral membrane proteins, 
makes difficult much of the biochemical studies. However, high 
interest in the biosynthetic pathways of phospholipids, one of the 
major components of the cell, drives steady progress in the field. 
 
Breakthrough in the studies on CDP-alcohol phosphatidyltransferase 
enzymes was made in 1956 by the identification of the requirement 
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for the CDP activation of choline and ethanolamine in lipid synthesis 
(Kennedy and Weiss, 1956).   
The first reports on purification of enzymes from this family from 
natural sources comes from 1976 when the 
phosphatidylglycerophosphate synthase from Escherichia coli and 
from Bacillus licheniformis were purified by substrate affinity 
chromatography (Dowhan, 2013; Hirabayashi et al., 1976; Larson et 
al., 1976). The proteins were solubilized with Triton X-100 (in the 
presence of glycerol) and CDP-diglyceride linked to sepharose was 
used in the crucial step of purification. A relatively high thermal 
stability for the E. coli protein was reported with the enzyme 
retaining its full activity after 5 min at 55 ˚C. Later, the pgsA gene of 
E. coli was cloned (Ohta et al., 1981), sequenced and confirmed to 
encode for phosphatidylglycerophosphate synthase in vitro 
(Gopalakrishnan et al., 1986). Similar purification procedures as for 
phosphatidylglycerophosphate were successfully used for 
phosphatidylserine synthase (Bae-Lee and Carman, 1984) and 
phosphatidylinositol synthase from Saccharomyces cerevisiae (Fischl 
and Carman, 1983). The latter purified enzyme was reconstituted into 
phospholipid vesicles and characterized in the absence of detergent 
(Fischl et al., 1986). Phosphatidylserine synthase from Saccharomyces 
cerevisiae was used to investigate the stereochemistry of the reaction 
using substrates stereospecifically labeled with O17 and O18 (Raetz et 
al., 1987). The reaction proceeds with inversion of configuration on 
the phosphorus, which suggests a single-displacement reaction 
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mechanism without formation of enzyme-bound intermediate (Figure 
1.9). 
 
 
Figure 1.9 Proposed reaction mechanism of phosphatidylserine synthase. This 
figure is taken from Raetz et al., 1987. 
 
The genes coding for yeast cholinephosphotransferase and 
ethanolaminephosphotransferase were sequenced in 1990 and 1991 
(Hjelmstad and Bell, 1991, 1990). The catalytic activity of these 
enzymes was shown to depend on the presence of divalent ions  with 
Mg2+ being the most activating ion followed by Mn2+ and Co2+ 
(McMaster et al., 1996). 
In 1998, mutagenesis of amino acid residues within the family 
consensus sequence pattern, DG(x)2AR(x)8G(x)3D(x)3D in 
cholinephosphotransferase from Saccharomyces cerevisiae was 
performed.  Mutations to alanine or glycine inactivated the enzyme in 
four point mutations of the 2nd, 5th, 6th and 7th residues of the sequence 
pattern (Williams and McMaster, 1998).  
A year later, the human choline/ethanolaminephosphotransferase 
was sequenced, cloned and expressed in yeast (Henneberry and 
McMaster, 1999). However, till today the choline- and 
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ethanolaminephosphotransferase have not been purified to 
homogeneity despite the variety of studies reported in vivo and 
partially purified cell extracts (Fagone and Jackowski, 2013). 
The above description underlines the major steps in the progress of 
biochemical studies on enzymes of the CDP-alcohol 
phosphatidyltransferase family. Further studies on the family 
enzymes from other organisms followed. Two of the major obstacles 
mentioned in the literature include purification to homogeneity and 
the need for detergents to extract and solubilize integral membrane 
proteins. These obstacles contributed to the lack of detailed 
information on the structure of any member of the CDP-alcohol 
phosphatidyltransferase family. The increasing data on the impact of 
point mutations on the enzyme´s activity (Cutler et al., 2003; Solís-
Oviedo et al., 2012) urge for atomic structure determination that 
would enable interpretation of these experiments and lead to a better 
understanding of the reaction mechanism. 
 
1.2.2 COMPATIBLE SOLUTES AND IPCT/DIPPS 
 
The enzymes of CDP-alcohol phosphatidyltransferase family have 
the requirement for a CDP activated substrate. Cytidylyltransferases 
of the nucleotidyltransferase family (PF00483) catalyze this activation 
for a variety of substrates. The CDP-L-myo-inositol myo-
inositolphosphotransferase (DIPPS; alternatively named di-myo-
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inositol phosphate phosphate synthase) from Archaeoglobus fulgidus 
and a number of other (hyper)thermophiles (Gonçalves et al., 2012) 
can be found fused with CTP:L-myo-inositol 1-phosphate 
cytidylyltransferase (IPCT), the enzyme that activates its substrate. 
This bifunctional enzyme is involved in the biosynthesis of a 
compatible solute di-myo-inositol-1,3´-phosphate (DIP).  
 
COMPATIBLE SOLUTES 
Compatible solutes are defined as small organic molecules that do 
not interfere with the cell function (Brown, 1976). Accumulation of 
compatible solutes is linked with adaptation of the organisms to 
extreme saline environment and high temperatures. Organisms with 
optimal growth temperature between 60˚C and 80˚C (thermophiles) 
and above 80˚C (hyperthermophiles) utilize some specific compatible 
solutes (Empadinhas and Da Costa, 2006).  Those often found in 
(hyper)thermophiles include glutamate, aspartate, trehalose, 
mannosylglycerate, glucosylglycerate, di-myo-inositol-phosphate, 
diglycerol phosphate, di-mannosyl-di-myo-inositol-phosphate, di-
myo-inositol-1,3´-phosphate (DIP). The last one, DIP, was found to 
accumulate rapidly in the cell upon supraoptimal temperatures 
(Gonçalves et al., 2003; Martins and Santos, 1995). The presence of 
DIP restricted to (hyper)thermopiles suggests a role in 
thermoadaptation (Gonçalves et al., 2003), further corroborated by 
protein stabilization studies in vitro (Santos et al., 2007). 
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IPCT/DIPPS 
In 2007, the biosynthetic pathway of DIP was described  and the 
genes of the enzymes involved were identified (Rodionov et al., 2007; 
Rodrigues et al., 2007). The first two steps of the reaction are 
catalyzed by the bifunctional enzyme IPCT/DIPPS (Figure 1.10). This 
enzyme consists of a cytoplasmic domain, IPCT, which activates L-
myo-inositol-1-phosphate with CTP to CDP-L-myo-inositol and 
releases pyrophosphate. The consecutive reaction catalyzed by the 
DIPPS domain couples CDP-L-myo-inositol with another molecule of 
L-myo-inositol-1-phosphate to form di-myo-inositol-1,3´-phosphate-1´-
phosphate. DIPPS, like other members of the CDP-alcohol 
phosphatidyltransferase family contains several transmembrane 
helices. The last step of the synthesis involves phosphate cleavage by 
a phosphatase and provides the compatible solute DIP. 
In the same enzyme, DIPPS was also shown to utilize CDP-glycerol 
as a substrate, in addition to L-myo-inositol 1-phosphate, leading to 
synthesis of a different compatible solute, glycero-phospho-myo-
inositol (GPI) (Rodrigues et al., 2007). GPI appears to be produced in 
response to combined osmotic and thermal stresses (Borges et al., 
2006).  
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Figure 1.10 Biosynthetic pathway of di-myo-inositol-1,3´-phosphate. 
Abbreviations: IPCT - CTP:L-myo-inositol 1-phosphate cytidylyltransferase, 
DIPPS - CDP-L-myo-inositol myo-inositolphosphotransferase, DIPP phosphatase - 
di-myo-inositol-1,3´-phosphate-1´-phosphate phosphatase. This figure is adapted 
from Rodrigues et al., 2007. 
The genes encoding for IPCT and DIPPS were found in 33 
(hyper)thermophiles within Archaea and Bacteria (Gonçalves et al., 
2012). Several of them encode the two enzymes in a separate gene 
products, however the majority of the identified genes encode for a 
bifunctional enzymes IPCT/DIPPS, where the genes were fused. It 
was also proposed that DIPPS evolved from phosphatidylinositol 
phosphate synthase of the phospholipid biosynthetic pathway 
(Gonçalves et al., 2012).  
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X-RAY STRUCTURE OF IPCT FROM ARCHAEOGLOBUS 
FULGIDUS 
The purification of the full-length bifunctional enzyme IPCT/DIPPS 
from Archaeoglobus fulgidus was unsuccessful (Rodrigues et al., 2007). 
Thus, the cytoplasmic IPCT domain alone has been expressed, 
purified, characterized and its crystallographic structure was solved 
(Brito et al., 2011). The IPCT activity was shown to be dependent on 
the presence of Mg2+. Interestingly, the products of IPCT were 
undetectable below 60˚C and the maximum activity was observed at 
90 – 95˚C. This optimal temperature for the enzyme activity is 10˚C 
above the optimal growth temperature of A. fulgidus. In the 
biosynthetic pathway of phosphatidylcholine, the CDP-choline 
synthesis by a cytidylyltransferase was shown to be the bottleneck in 
the phospholipid synthesis (Vance, 2002). It is not known if the same 
applies to the synthesis of DIP, however, the observed optimum 
temperature for IPCT activity is consistent with the increase of the 
cellular DIP concentration at supraoptimal temperatures for A. 
fulgidus (Gonçalves et al., 2003).  
The structure of IPCT from A. fulgidus was solved at 1.9 Å resolution 
(Figure 1.11; Brito et al., 2011). Two subdomains have been defined. 
The core subdomain has a seven-stranded β-sheet in the central part 
surrounded by 6 helices, a similar fold to the dinucleotide-binding 
Rossmann fold. The sugar binding subdomain consists of three-
stranded short β-sheet. A pocket between the two subdomains forms 
the active site, which includes the signature sequence of 
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nucleotidyltransferases, G-X-T-R-(X)4-P-K, and binds a citrate 
molecule in the crystal structure (Figure 1.11). Based on the 
comparison with homologous structures obtained with substrates, 
the IPCT substrates were fitted into the active site. Analysis of the 
CTP-fitted model provides clues regarding the strict substrate 
specificity for the CTP over other nucleosides. It was proposed that a 
tight loop (His89 - Gly95, numbering following Brito et al., 2011) 
excludes binding of purines and an additional H-bond formed 
between NH2 amino group of cytidine and the main chain oxygen of 
Pro92 favors CTP over UTP binding. 
 
 
Figure 1.11 IPCT structure with citrate bound in the active site. Protein secondary 
structure is shown in cartoon and the citrate in stick representation. This figure is 
taken from Brito et al., 2011.  
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2.1 INTRODUCTION 
 
α-Phosphoglucomutase (α-PGM) (E.C. 5.4.2.2) is present in all 
organisms from bacteria to animals and plants (Whitehouse et al., 
1998). This enzyme catalyzes the interconversion of α-glucose 
1-phosphate to glucose 6-phosphate, and plays distinct roles among 
the different organisms. In animals and plants, α-PGM is mainly 
involved in the synthesis and utilization of storage carbohydrates like 
glycogen and starch (Fettke et al., 2009; Villar-Palasi and Larner, 
1970). In bacteria, α-PGM is involved in sugar utilization and also in 
the synthesis of UDP-glucose, a sugar donor for the production of 
glucose-containing polysaccharides. Number of studies associated the 
virulence of several pathogens to the presence of α-PGM (Paterson et 
al., 2009; Plant et al., 2006).  
Lactococcus lactis is a lactic acid bacterium widely used in starter 
cultures for the manufacture of fermented dairy products, such as 
cheese and buttermilk. Its enormous economical value has rendered 
this typical homofermentative bacterium as one of the most 
extensively studied members of the lactic acid bacteria. L. lactis 
possesses two distinct PGMs with specificity for α- or β-anomers of 
phosphoglucose. β-PGM, a member of the haloacid dehalogenase 
superfamily (HADSF) class I, catalyzes the reversible conversion of β-
glucose 1-phosphate to glucose 6-phosphate, and is involved in the 
degradation pathways of maltose and trehalose (Andersson et al., 
2001; Lahiri et al., 2002; Levander et al., 2001). α-PGM of L. lactis 
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(APGM) catalyzes the interconversion of α-glucose 1-phosphate to 
glucose 6-phosphate, and is essential in the utilization of galactose via 
the Leloir pathway (Grossiord et al., 1998; Neves et al., 2006). APGM 
is also implicated in the synthesis of precursors for cell wall 
polysaccharides and exopolysaccharides (Delcour et al., 1999; 
Kleerebezem et al., 1999). Therefore, APGM plays an important role 
in the processes of galactose degradation and formation of precursors 
for biosynthetic pathways during growth on glucose or other 
carbohydrates. 
In contrast with most bacterial and eukaryotic α-PGMs that utilize α-
glucose 1-phosphate and belong to the α-D-phosphohexomutase 
superfamily (IPR005841), the lactococcal enzyme belongs to the 
HADSF (Neves et al., 2006). This superfamily comprises more than 
3000 proteins, which are mainly involved in phosphoryl transfer 
reactions (Allen and Dunaway-Mariano, 2004). Members of the 
HADSF are typically composed of two domains: the core and cap 
domains. The core domain contains most of the conserved catalytic 
residues, while the cap domain acts as a lid over the core domain and 
differentiates according to specific substrates and catalytic reaction 
(Allen and Dunaway-Mariano, 2009; Lahiri et al., 2004). An example 
of a strictly conserved amino acid residue is the aspartate that acts as 
a nucleophile and mediates the transfer of the phosphoryl group 
(Asp8 in APGM). Members of the HADSF also share the catalytic 
requirement for a metal cofactor, usually Mg2+. Phylogenetic studies 
with HADSF proteins suggested a common origin for APGM and the 
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eukaryotic phosphomannomutases (PMMs; IPR005002) (Neves et al., 
2006). However, APGM shows strict specificity for α-glucose 
1-phosphate, whereas the eukaryotic phosphomannomutases 
generally use both α-mannose 1-phosphate and α-glucose 1-
phosphate as substrates. Noteworthy, the sequence identity between 
α- and β-phosphoglucomutase from L. lactis is only 10% (belonging to 
distinct clades of phylogenetic tree; Neves et al., 2006) and results in 
significant structural differences, namely the topology and position of 
the cap domain in the sequence. These observations suggest that L. 
lactis APGM is mechanistically closer to the PMMs than to the β-
PGMs. 
In this work, we report the first crystal structure of APGM 
determined by single-wavelength anomalous dispersion (SAD) 
method based on a Pt derivative and refined to 1.5 Å resolution. The 
structure is compared with other members of the HADSF and specific 
features of the enzyme with impact on substrate specificity and 
catalytic mechanism are discussed. 
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2.2 PRODUCTION AND CRYSTALLIZATION OF 
α–PHOSPHOGLUCOMUTASE FROM 
LACTOCOCCUS LACTIS 
 
2.2.1 MATERIALS AND METHODS 
2.2.1.1 CLONING, EXPRESSION AND PURIFICATION 
The nucleotide sequence pgmH, encoding APGM was amplified by 
PCR from Lactococcus lactis subsp. cremoris, strain NZ9000, using 
forward primer 5’CATGCCATGGGCCATCATCATCATCATCAT 
GACGACGACGACAAGATGAAAAAAATATTAAGT3’ and reverse 
primer 5’GCTCTAGATTAAGCTTCTTCCATCGCAATAATTGCTT 
TTAGAATAGCTGCAG3’. The gene was cloned into the pNZ8048 
vector introducing a hexahistidine (His6) tag at the N-terminus, 
followed by an enterokinase cleavage site. The cloned DNA sequence 
was confirmed to be correct by AGOWA GmbH DNA sequencing 
service. 
Homologous expression was performed in L. lactis, strain NZ9000, 
grown in a 5 liter fermentor with M17 medium (Difco) containing 
0.5% glucose, 5 mg l-1 chloroamphenicol at 303 K in anaerobic 
conditions with controlled pH of 6.5. At OD600nm of 0.5 the protein 
overexpression was induced by adding nisin to a final concentration 
of 1 μg l-1 and subsequently grown for further 2 h. The biomass was 
harvested by centrifugation at 4000g, resuspended in 50 mM 
phosphate buffer pH 8.0, 300 mM NaCl, 20 mM imidazole and lysed 
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using a French Press. The cell debris w
at 30000g for 1 h. The soluble extract was loaded on
Superflow Cartridge (Qiagen). The column was washed with 
phosphate buffer pH 8.0, 600 mM 
UV absorbance at 280 nm reached 
used with 50 mM phosphate buffer pH 8.0
imidazole as the elution buffer. The purity of the protein was 
assessed by SDS-PAGE (Figure 2.1)
a functional assay for α-phosphoglucomutase activity as described 
previously (Neves et al., 2006) (data not shown).
was exchanged to 10 mM HEPES pH 7.4 and protein concentrated to 
about 10 mg ml-1 using Vivaspin concentrators with 10 kDa 
molecular-weight cutoff. The protein sample was divided in
aliquots, flash frozen in liquid nitrogen and stored at 193 K
 
 
 
 
 
 
 
Figure 2.1 SDS-PAGE of purified
stained with Coomassie blue. Lane 
from BioRad (Precision Plus Protein Standards
µg). 
as removed by centrifugation 
to a 5 ml Ni-NTA 
50 mM 
NaCl, 20 mM imidazole until the 
baseline. A gradient elution was 
, 300 mM NaCl, 500 mM 
 and its activity was confirmed by 
 The sample buffer 
to 100 µl 
.  
 30 kDa APGM (construct with His tag) 
M, molecular-weight marker (kDa) 
); lane P, protein sample (10 
  
2.2.1.2 CRYSTALLIZATION 
Screening of the crystallization conditions was performed 
Cartesian Mini-Bee nano-robot at 293 K
the Classics II suite from Qiagen. 
were prepared by mixing 100 nl of protein sample and 100 nl of 
reservoir solution. Multiple needle
the crystallization condition containing 2 
HEPES pH 7.5 and 2% PEG 400 (Figure 2.
from this condition, led to the 
crystals (Figure 2.2b).  
 
Figure 2.2 Crystals of APGM. (a) Crystals obtained in 
pH 7.5 and 2% PEG 400. (b) Crystals grown without PEG 400. 
streak seeding into the crystallization solution with 2% PEG 400 from needles; 
multiple plates. 
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with 
 using the Classics suite and 
The crystallization sitting drops 
-shaped crystals were obtained in 
M ammonium sulfate, 0.1 M 
2a). Removal of PEG 400 
formation of multiple plate-like 
 
2 M ammonium sulfate, 0.1 M HEPES 
(c) Crystals obtained using 
(d) or 
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Crystal optimization included streak seeding trials from both, needle 
and plate multiple crystals, into new crystallization solutions 
comprising 2 M ammonium sulfate and 0.1 M HEPES pH 7.5. A cat 
whisker was used to touch the crystal and seeds were immediately 
transferred in one quick movement across the new drop. Multiple 
crystals appeared showing similar shapes as the crystals used for 
seeding (not shown). Furthermore, streak seeding of needles, grown 
in the presence of PEG 400, into the same crystallization condition 
yielded single tiny crystals, but not suitable for diffraction 
experiments (Figure 2.2c). 
The crystallization procedure was optimized, so that single hexagonal 
plate crystals were obtained by cross seeding of multiple plate 
crystals, grown in the absence of PEG 400 and transferred after 24 h 
equilibration into crystallization solutions containing 1.9 – 2.1 M 
ammonium sulfate, 0.1 M HEPES pH 7.5 and 2% PEG 400 (Figure 
2.2d). Hanging drops were prepared by mixing protein and reservoir 
solutions in ratios 2:1, 1:1 and 1:2 (µl), equilibrated against 500 µl of 
reservoir at 293 K. 
 
2.2.1.3 DATA COLLECTION AND PROCESSING 
Crystals were transferred from the drop with a cryoloop into a new 
drop containing the crystallization solution supplemented with 20% 
glycerol and flash-cooled in liquid nitrogen. 
X-ray diffraction data were collected on beamline ID 14-2 at the 
European Synchrotron Radiation Facility (ESRF, Grenoble) at 100 K. 
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1400 images with an oscillation angle of 0.1˚ and an exposure time of 
1.5 s per frame were recorded with an ADSC Q4 CCD detector at a 
wavelength of 0.9334 Å. Data were integrated using MOSFLM (Battye 
et al., 2011) and scaled with SCALA (Evans, 2006). The Matthews 
coefficient was calculated using the CCP4i package (Collaborative 
Computational Project, Number 4, 1994; Potterton et al., 2003; Winn 
et al., 2011). 
 
Table 2.1 Data collection and processing. 
Values for the outer resolution shell are given in parentheses. 
X-ray source ESRF, beamline ID 14-2 
Wavelength (Å) 0.9334 
Temperature (K) 100 
Detector ADSC Q4 
Rotation range per image (°) 0.1 
Space group P3121/P3221 
Unit-cell parameters (Å) a = b = 67.2, c = 210.4 
Resolution range (Å) 33.00 - 1.50 (1.58 - 1.50) 
Total No. of reflections 744514 (105892) 
No. of unique reflections 89350 (12888) 
Completeness (%) 100.0 (100.0) 
Average multiplicity 8.3 (8.2) 
Average I/σ(I) 16.8 (3.1) 
Rmeas 0.089 (0.754) 
Overall B factor from Wilson plot (Å2) 15.9 
Rmeas = Σhkl{N(hkl)/[N(hkl)-1]}1/2 Σi|Ii(hkl) - <I(hkl)>| / ΣhklΣiIi(hkl), where Ii(hkl) is the observed 
intensity, <I(hkl)> is the average intensity for multiple measurements and N is the number of 
times a given reflection has been observed. 
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2.2.2 RESULTS AND DISCUSSION 
 
The homologous expression of APGM in L. lactis was successfully 
achieved. Purification of APGM by affinity chromatography was 
sufficient to produce pure and functional protein (Figure 2.1) with a 
yield of ~ 1.5 mg l-1. The problem of crystal multiplicity observed 
during the initial screens was overcome by seeding techniques. Single 
hexagonal crystals were obtained by streak seeding from multiple 
crystals grown in ammonium sulfate in the absence of PEG 400 into 
the same crystallization solution supplemented with 2% PEG 400. 
Crystals grew up to 150 µm within one week after the streak seeding 
(Figure 2.2d). Later on, these new single crystals obtained from 
seeding were used as the initial source of seeds. Crystals diffracted to 
1.5 Å resolution and belonged to the trigonal space group P31,221 with 
unit cell parameters a=b= 67.17 Å and c= 210.39 Å. The calculated 
Matthews coefficient (Kantardjieff and Rupp, 2003; Matthews, 1968) 
is 2.3 Å3/Da with a solvent content around 46% indicating the 
presence of two molecules in the asymmetric unit. The relevant 
parameters for data collection and processing are summarized in  
Table 2.1. 
A BLAST search revealed highest identity of APGM sequence with 
phosphomannomutases (around 22-24%). The best three hits, for 
which the three-dimensional structure are available, were used as 
search models for molecular replacement (human 
phosphomannomutase 2, PDB code 2amy, to be published; human 
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phosphomannomutase 1, PDB code 2fue, (Silvaggi et al., 2006); and 
Leishmania phosphomannomutase, PDB code 2i54, (Kedzierski et al., 
2006)). No solution was found in the various molecular replacement 
trials with Molrep (Vagin and Teplyakov, 1997) and Phaser (McCoy 
et al., 2007). Therefore, the phase problem still needed to be 
addressed by experimental phasing, which is described in Section 
2.3.1.4. 
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2.3 HIGH-RESOLUTION STRUCTURE OF AN 
ATYPICAL α–PHOSPHOGLUCOMUTASE 
 
2.3.1 MATERIALS AND METHODS 
2.3.1.1 CRYSTALLIZATION 
The crystallization of APGM was performed as described in section 
2.2.1.2 (Nogly et al., 2012). Native crystals were soaked at room 
temperature in crystallization solutions supplemented with a heavy-
atom compound. The soaking times were 20 h for K2PtCl4, K2Pt(NO2)4, 
C5H11O2Pb, C9H9HgNaO2S and KAuCl4, and 1 month for 
Hg(CH3COO)2 and Pt(NH3)2Cl2. The final concentration of these 
compounds ranged from 2.5 to 15 mM. 
2.3.1.2 GEL FILTRATION 
Size-exclusion chromatography was carried out to estimate the 
molecular mass of APGM in solution, using a Superdex 200 16/60 gel 
filtration column equilibrated with 50 mM HEPES pH 7.4 and 150 
mM NaCl. The calibration curve was prepared using as standards 
cytochrome c, carbonic anhydrase, albumin (BSA), alcohol 
dehydrogenase and β-amylase. 
 
2.3.1.3 DATA COLLECTION AND PROCESSING 
The data set from the crystal derivatized with K2PtCl4 was collected to 
2.4 Å resolution at the I04 beamline of the Diamond Light Source 
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(DLS, Didcot), at 100 K, and the diffraction data were integrated and 
scaled with XDS (Kabsch, 2010). The other putative derivative data 
sets (data not shown) were measured at the ESRF, DLS or SLS (Swiss 
Light Source, Villigen) and processed with XDS. 
 
2.3.1.4 PHASING AND CRYSTALLOGRAPHIC REFINEMENT 
HKL2MAP graphic interface (Pape and Schneider, 2004) and 
SHELXD (Schneider and Sheldrick, 2002) were used to search all the 
putative derivatives for heavy atom sites. The only clear solution was 
observed for the K2PtCl4 derivative, yielding 23 positive hits out of 
100 trials, the best solution showing correlation coefficients CCall = 
37.6% and CCweak = 21.6%. A total of 5 probable Pt sites were found 
with occupancies higher than 0.3 in space group P3121. However, 
SHELXE (Sheldrick, 2002) did not produce an interpretable electron 
density map. Therefore, the initial set of 5 sites was input to 
SHARP/autoSHARP (Bricogne et al., 2003; Vonrhein et al., 2007) for 
further refinement and phasing, with phasing power (anomalous) of 
1.622 and figure of merit (acentric) 0.343. After density modification 
with Solomon (Abrahams and Leslie, 1996) an interpretable electron 
density map was obtained at 2.4 Å resolution. The phase extension to 
include the higher resolution native data set was not successful, very 
likely due to the non-isomorphism between the Pt derivative and the 
native crystals. Nevertheless, a partial backbone model of the protein 
was built with Buccaneer (Cowtan, 2006). Based on this incomplete 
model, it was possible to identify the non-crystallographic symmetry 
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(NCS) between the two molecules in the asymmetric unit. The NCS 
symmetry operator was used for density modification in DM 
(Cowtan, 1994) which further improved the quality of the calculated 
electron density maps. Cycles of automated model building with 
Buccaneer, ARP/wARP (Langer et al., 2008) alternating with manual 
model building using Coot (Emsley et al., 2010), yielded a 
crystallographic model about 80% complete. Molecular replacement 
was then successfully carried out with Phaser (McCoy et al., 2007) 
using this partial model as a search template against the higher 
resolution native data set. The structure was completed and refined 
to 1.5 Å resolution using Coot and Refmac5 (Murshudov et al., 1999). 
In the final refinement cycles, the model was refined using TLS 
groups as generated with TLSMD server (Painter and Merritt, 2006) 
and with hydrogen atoms added in the ideal positions with 
MolProbity server (Chen et al., 2010) used as riding atoms. 
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Table 2.2 Data collection and processing of Pt derivative and structure refinement. 
Data collection and processing of Pt derivative 
data  
 
X-ray source DLS, beamline I04 
Wavelength (Å) 0.9722 
Temperature (K) 100 
Detector ADSC Quantum 
Q315r 
Rotation range per image (°) 0.4 
Space group P3121 
Unit-cell parameters (Å) a = b = 67.4, c = 212.6 
Resolution range (Å) 50.00 - 2.40 (2.54 – 
2.40) 
Total No. of reflections 129424 (17888) 
No. of unique reflections 41740 (6489) 
Completeness (%) 98.5  (95.1) 
Average multiplicity 3.1 (2.8) 
Average I/σ(I) 25.76 (10.91) 
Rmeas 0.034 (0.109) 
Overall B factor from Wilson plot (Å2) 42.6 
Statistics on refinement of native data  
Resolution (Å) 30.0-1.50 
No. reflections 89298 
Rwork / Rfree 0.155/ 0.178 
R.m.s. deviations  
    Bond lengths (Å) 0.016 
    Bond angles () 1.752 
Statistics are given treating Bijvoet mates as separate observations. 
Values for the higher resolution shell are given in parentheses. 
Rmeas = Σhkl{N(hkl)/[N(hkl)-1]}1/2 Σi|Ii(hkl) - <I(hkl)>| / ΣhklΣiIi(hkl), where Ii(hkl) is the 
observed intensity, <I(hkl)> is the average intensity for multiple measurements and N 
is the number of times a given reflection has been observed. 
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2.3.2 RESULTS AND DISCUSSION 
2.3.2.1 MODEL QUALITY AND APGM STRUCTURE 
The APGM crystal soaked with K2PtCl4 diffracted to 2.4 Å and 
belonged to space group P3121 with unit cell dimensions of a = b = 
67.4 Å and c = 212.6 Å. Two molecules are present in the asymmetric 
unit corresponding to a solvent content around 47.4%. The structure 
of APGM was solved by single wavelength anomalous scattering 
(SAD) using the K2PtCl4 derivative. Relevant parameters for data 
collection and processing of the derivative data are shown in Table 
2.2. The final APGM model was refined to 1.5 Å resolution with Rfactor 
of 15.5% and Rfree of 17.8% (Brünger, 1992). The crystallographic 
model showed good geometry (rmsd bond length 0.0159, rmsd bond 
angle 1.7482) and stereochemistry (PROCHECK, Laskowski et al., 
1993). All amino acid residues lie within the allowed regions of the 
Ramachandran plot (RAMPAGE, Lovell et al., 2003).  
The electron density maps are very well defined for the protein 
backbone, except for the region comprising Ile9 and Asp10 in 
molecule B. The side-chains of 12 surface residues are not fully visible 
in the final 2|Fo|-|Fc| electron density map contoured at 1σ, likely 
due to their mobility, and 27 side-chains were modeled with alternate 
conformations, including the catalytic residue Asp8. A blob of 
residual electron density was observed near the active site of the 
enzyme (cap domain). Based on its tetrahedral shape and nearby 
residues, a sulfate ion was fitted into the blob and further refined. Six 
glycerol molecules were added to the model, one of which is close to 
  
the sulfate ion in chain B. The final 
amino acid residues (252 per chain
ions and 6 glycerol molecules. 
Each molecule comprises a core domain 
typical of HADSF, and a small cap domain
illustrated in Figure 2.3.  
 
Figure 2.3 APGM ribbon representation (molecule B), colored according to secondary 
structure elements assigned with DSSP (Kabsch and Sander, 1983)
(yellow β-strands, magenta α-helices, pink turns, sphere hinges). Glycerol and sulfate 
located at the interface of the core and cap dom
codes used in this chapter, unless stated otherwise
were drawn with CCP4MG (McNicholas et al., 2011)
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APGM model comprises 504 
), 606 water molecules, 2 sulfate 
(residues 1-88 and 189-252), 
 (residues 93-183) as 
 
 and hinges by HingeProt 
ains are drawn in stick mode. Atom color 
: C - green, O - red and S – yellow. Figures 
. 
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The core domain consists of a seven-stranded β-sheet (5, 4, 3, 2, 1, 10 
and 11) flanked by five α-helices (6, 7, 8, 1 and 2; refer to Figure 2.5 
for numbering). The cap domain is constituted by a four-stranded 
antiparallel β-sheet (6, 7, 9 and 8) with three α-helices located on one 
face (3, 5 and 4). The cap and core domains are connected by two 
linker loops (89-92 and 184-188) that may act as a hinge joint. Indeed, 
HingeProt (Emekli et al., 2008) predicts a more mobile region around 
residues 88 and 188 (Figure 2.3).  
The APGM active site is located at the interface between the core and 
cap domains. This interface comprises several positively charged 
residues, such as Lys17 and Lys44 in the core domain, and Arg128, 
Lys140 and Lys146 in the cap domain, which are proposed to keep 
the enzyme in an open conformation. Upon binding of the negatively 
charged substrate (i.e. α-glucose 1-phosphate) in cap domain, the 
electrostatic repulsion between the cap and core domains is shielded, 
favoring the closure of the cap domain and proper positioning of the 
substrate with respect to catalytic residues in the core domain. A 
closed cap domain also provides a solvent-excluded environment. 
The core domain contains the conserved catalytic residues of the 
HADSF (see more details below), while the cap domain has more 
variable size and structure, and thus is proposed to be involved in 
substrate recognition. The topology and location of the cap domain 
allows the classification of APGM within the type IIb subfamily of the 
HADSF (Allen and Dunaway-Mariano, 2004).  
 
  
2.3.2.2 HOMOLOGOUS STRUCTURE
The overall structure of APGM is similar to 
phosphomannomutases (PMMs), d
(up to 24%). The four best hits in DALI were (PDB entries, Z
and rmsd for C superposition are indicated for each hit):
mexicana PMM (2i55, 23.7, 2.9 Å), Trypanosoma brucei
3.0 Å), human PMM1 (2fue, 20.1, 
17.4, 5.3 Å (Kedzierski et al., 2006; Silvaggi et al., 2006
of APGM with these four crystal structures 
domain is more tightly closed in APGM 
 
Figure 2.4 Structural superposition of APGM and PMMs aligned by the core domains (with 
SwissPDBViewer, Guex and Peitsch, 1997) showing the different conformations of the cap 
domain relative to the core domain. APGM (depicted in red) being the most close
PDB code identifies the PMM structures:  2i55 
PMM1, 2amy - human PMM2 and 3f9r - Trypanosoma brucei
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S 
eukaryotic 
espite their low sequence identity 
-scores 
 Leishmania 
 PMM (3f9r, 24.2; 
4.1 Å) and human PMM2 (2amy, 
). Superposition 
shows that the cap 
than in PMMs (Figure 2.4).  
 
d one. The 
- Leishmania Mexicana PMM, 2fue - human 
 PMM. 
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In contrast, the structure of human PMM2 (2amy) without any ligand 
bound at the domains interface, has the cap domain furthest away 
from the core domain. The structure of leishmanial PMM (2i55) 
illustrates the cap closure upon ligand binding: polypeptide chain A 
has no ligand at the active site, whereas chain B has a ligand bound 
and thus is in a more closed conformation. This ligand, glucose 1,6-
bisphosphate, is extensively interacting with both domains. 
Remarkably, the structure of human PMM1 bound to mannose 1-
phosphate (2fue) was captured in a cap open state, with the substrate 
interacting mainly with residues from the cap domain. This structure 
was obtained by soaking the ligand into pre-formed crystals, which 
was suggested to restrict the movements of the cap domain within 
the crystal lattice (Silvaggi et al., 2006). 
Sulfate binding at the active site, as in APGM and in 3f9r, rather than 
larger ligands, as in 2i55 and 2fue, is likely to allow a more closed 
conformation of the cap domain. However, the structure of T. brucei 
PMM with sulfate displays a more open conformation than APGM. 
The positive patch at the cap-core interface of Trypanosoma PMM 
comprises Arg19 and Lys50 in the core domain, and Arg122, Arg133 
and Arg140 in the cap domain, and is highly conserved among 
PMMs. However, in APGM, the Lys140 side-chain (corresponding to 
Arg133 of 3f9r) is oriented towards the solvent, which could mitigate 
the electrostatic repulsion between the positively charged residues at 
the APGM domains interface, thus allowing a more tightly closed cap 
conformation. 
  
APGM shows several insertion regions with regard to
2.5), located mainly at the molecular surface of the
namely between α2 – β3, β4 – β5, α3 
These insertions are not expected to cause major 
differences in APGM as compared to PMMs
cap domain, as discussed in the next section
 
Figure 2.5 Amino acid sequence alignment based on structural superimposition of APGM 
with PMMs performed with the Dali server. Black arrows indicate domain boundaries. 
Relevant amino acid residues are displayed in bold; residue color cod
substrate interaction, blue overline - positive charged residues at cap
forming dimer interface. Below the sequence alignment, conserved residues are indicated by 
an asterisk (*) and similar residues by a dot (.). Blue arrows represent β
α-helices. PDB codes refer to structures of: 3f9r 
Leishmania Mexicana PMM, 2fuc – human PMM1
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 PMMs (Figure 
 core domain, 
– β6 (cap domain) and α6 – β10. 
structural 
, except for the one at the 
.  
 
e: red – involved in 
-core interface, green – 
-strands and red tubes 
– Trypanosoma brucei PMM, 2i55 – 
, 2amy – human PMM2.  
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2.3.2.3 QUATERNARY STRUCTURE
The crystal asymmetric unit of APGM contains two molecules;
rmsd upon Cα superposition of both molecules (chains A and B) is 
0.35 Å, indicating very similar structures. The molecular mass of 
APGM estimated by size-exclusion chromatography was 
indicating a dimeric form in solution. The 
by PISA (Krissinel and Henrick, 2007)
of APGM structure (Figure 2.6). The a
essential role of the interface in complex formation
 
Figure 2.6 APGM dimer identified by PISA. Molecule B is colored in blue and molecule A in 
green (dark color for the core and light for the cap domain). Sulfate 
at the substrate binding site. 
 
The occluded area at this dimer interface is approximately 1000 Å
(around 5% of the total area) and is
acid residues located mainly at the
 
 the 
55 kDa, 
dimeric assembly proposed 
 corresponds to a crystal contact 
chieved score (CSS) suggests an 
.  
 
and glycerol are located 
2 
 formed by hydrophobic amino 
 C-terminal helix α8, and 
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hydrophilic residues sited on the stretch between β11 and α8 (core 
domain). It also includes waters mediating H-bonds between the two 
molecules. This dimeric arrangement should represent the biological 
unit of APGM and may be relevant for the enzyme function, as it 
brings the active sites within the dimer into proximity. It is worth 
noting that in APGM, helix α8 is more shifted away from the β-sheet 
of the same monomer towards α8 and β11 of the other monomer than 
in PMMs, and thus forming a hydrophobic groove accommodating 
residues sited on α8 of the other molecule within the dimer. 
The dimeric assembly proposed for L. mexicana PMM (Figure 2.7) 
shows a different interface formed exclusively by amino acid residues 
from the cap domains (Kedzierski et al., 2006). The dimer formation 
involves a helix-helix interaction between the first helices (α3) and an 
antiparallel β-sheet interaction between the first strands (β6) of the 
two cap domains, which extends the solvent exposed face of the β-
sheet, placing the two active sites adjacent to each other. This 
interface is also conserved in human PMMs (Silvaggi et al., 2006) and 
likely in T. brucei PMM (as predicted by PISA server). 
Structure based sequence alignment of APGM with these four 
homologous PMMs shows a 5-residue-insertion in this region of the 
cap domain, between helix α3 and strand β6 (Figure 2.5). Structural 
superposition reveals that APGM adopts a different conformation for 
the loop comprising Leu110 to Glu123, including a protrusion 
(Glu115-Glu123) facing outwards, which could indicate that APGM 
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may not form a similar dimeric assembly 
PMMs structures (Figure 2.7). 
 
Figure 2.7 Dimer of leishmanial PMM (grey) illustrating the conserved dimeric interface of 
eukaryotic PMMs. Superimposition with one molecule of APGM (core 
cyan) by cap domain highlights the longer loop in APGM.
 
2.3.2.4 ACTIVE SITE AND CATALYTIC MECHANISM
APGM catalyzes the interconversion of α
glucose 6-phosphate via a phophorylated enzyme intermediate, as 
proposed for other phosphryl transfer enzymes of HADSF 
2006; Kedzierski et al., 2006). The enzyme has to be first activated by 
transfer of a phosphate from the 
enzyme aspartyl nucleophile (Asp8 in APGM) producing an aspartyl
as the aforementioned 
 
- dark blue, cap - 
 
 
-glucose 1-phosphate to 
(Dai et al., 
α-glucose 1,6-bisphosphate to the 
-
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phosphate. The substrate (α-glucose 1-phosphate) binds, forming a 
covalent bond between the substrate C6 hydroxyl oxygen and the 
aspartyl-phosphate phosphorous. A α-glucose-1,6-bisphosphate 
intermediate is generated, which then needs to be released from the 
enzyme and rebound in a reoriented position so that the 1-phosphate 
is transferred to the aspartyl nucleophile, replenishing the activated 
form of the enzyme and forming the final product (glucose 6-
phosphate). Release of the phosphate from the bisphospho-
carbohydrate intermediate to the aspartyl is facilitated by another 
acid/base group (Asp10). The catalytic nucleophile (Asp8) usually 
coordinates a magnesium ion along with other residues and water 
molecules. No metal ion is observed in the APGM crystal structure, 
and no Mg2+ ions were present in the crystallization buffer. 
Although the relevance of the APGM dimer to its catalytic activity 
has not yet been demonstrated, in this arrangement the two active 
sites are placed face-to-face, with the sulfate ions ~38 Å apart. 
Interestingly, an extended positively charged patch is observed in a 
groove between the active sites, comprising two arginines 
(Arg234A/B) and two lysines (Lys237A/B) residues. This structural 
configuration can contribute to an efficient turnover, if the 
bisphosphorylated sugar intermediate can be released from the one 
active site and immediately captured (in the inverted orientation) by 
the nearby active site of the second monomer in the dimer. Moreover, 
the positive charge between the active sites may prolong the presence 
of the intermediate within the dimer instead of being released to the 
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solution. A functional role was also proposed for the dimeric form of 
human and leishmanial phosphomannomutases (Kedzierski et al., 
2006; Silvaggi et al., 2006).  
The unsuccessful attempts to obtain the structure of APGM in 
complex with substrate analogues, either by crystal soaking or co-
crystallization may be due to the presence of sulfate at the APGM 
active site (Lu et al., 2005). Nevertheless, important information on 
substrate binding can be derived from the homologous PMM 
structures, in particular those of human PMM1 in complex with α-
mannose-1-phosphate and leishmanial PMM with β-glucose-1,6-
bisphosphate. In fact, the sulfate bound at the active site of APGM 
molecules A and B overlays quite well with the phosphoryl group 
(bound to C1) of glucose-1,6-bisphosphate bound to the L. mexicana 
PMM structure (Figure 2.8). Moreover, if the cap domains of APGM 
and human PMM1 structures are superposed, the sulfate ion in 
APGM also matches the position of the phosphoryl group of α-
mannose-1-phosphate. In the APGM structure, the sulfate is H-
bonded to main-chain amide and side-chain hydroxyl groups of 
Thr177, Thr178, Thr179, Lys146 and a few water molecules. It is also 
close to Gln43 from the core domain (~4.1 and 3.1 Å in molecules A 
and B, respectively). In all four eukaryotic PMM structures from the 
DALI survey, this distal sulfate/substrate phosphoryl binding pocket 
(cap domain) is composed mainly by two arginines and one serine 
(Arg143, Arg150 and Ser188, human PMM1 numbering). 
 
  
Figure 2.8 Superposition of APGM and leishmanial PMM structures, highlighting the 
alignment of glycerol and sulfate (APGM; C -
glucose 1,6-bisphosphate (leishmanial PMM; C 
 
In addition, the glycerol found near the sulfate ion (
closest distance is 4.1 Å) also aligns 
pyranose ring of β-glucose-1,6-biphosphate bound to 
PMM structure. In APGM, the two hydroxyl groups of glycerol
mimic part of the sugar moiety establish
side-chains of Arg128 and Asn181
Asp180 in leishmanial PMM), main
hydrogen of Gly42 and a few water molecules
in the APGM structure, the side-chain of Asp10 is H
glycerol hydroxyl (corresponding to C6 hydroxyl of 
in molecule B, while in molecule A, in the absence of glycerol, it is 2.8 
Å shifted towards the interior of the active site pocket. On the 
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 green; alternate conformation in Asp8) with 
– grey; P - magenta). 
molecule B, 
very well with part of the 
the leishmanial 
 that 
 hydrogen bonds with the 
 (corresponding to Arg122 and 
-chain amide group peptide 
. It is worth noting that 
-bonded to one 
the PMM ligand) 
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contrary, in PMMs, the corresponding Asp side-chain is further away 
from the ligand (~7 Å from the C6 atom of glucose in leishmanial 
PMM), except for the human PMM1 where the acid/base Asp is in a 
conformation corresponding to molecule B of APGM. The mobility of 
Asp10, which plays an important role in the catalytic mechanism, is 
clearly evident by the different positions adopted by this acid/base 
residue in APGM and PMMs. Also, the poorly defined electron 
density around the backbones of Ile9 and Asp10 in molecule B, 
suggests flexibility and possibly alternate conformations. 
Moreover, we have fitted α-glucose-1,6-biphosphate into APGM, 
based on the previous superposition with leishmanial PMM, and a 
model with reasonable stereochemistry was obtained except for 
Ser41, which lies too close (1.3 Å) to the phosphoryl group (Figure 
2.8). This residue is replaced by a conserved glycine in PMMs. A shift 
of the molecule towards Asp8 and a slight rotation around the 
phosphodiester bond followed by geometry idealization with 
refmac5 (Murshudov et al., 1997), provided a good fit of the ligand 
into the binding pocket (Figure 2.9). 
A relevant point to discuss is the strict specificity of APGM towards 
α-glucose 1-phosphate, in contrast to PMMs that can use both α-
glucose 1-phosphate and α-mannose 1-phosphate as substrates. The 
only difference between these two sugars is the position of the 
hydroxyl group on C2 of the pyranose ring (equatorial in α-glucose 1-
phosphate and axial in α-mannose 1-phosphate). 
  
Figure 2.9 Active site of APGM fitted with glucose 1,6
by structure idealization). Van der Waals surfaces of Gln43 side
ligand are colored in green and pink, respectively, highlighting the steric restrictions 
imposed by Gln43 below the C2 atom of the sugar ring.
 
Structural superimposition of APGM with
that the side-chain of Gln43 in APGM lies in 
the pyranose ring of α-glucose-1,6-bis
Å away from C2). This residue restricts the space under the sugar 
ring, which may be needed to accommodate the 
phosphate (Figure 2.9). If the hydroxyl group of C2 is in the axial 
position, as in α-mannose-1,6-bisphosphate
side-chain of Gln43. This steric hindrance in the presence of 
1-phosphate may prevent the full closure of the cap over the core 
domain and restrict the proper positioning of the phosphomannose to 
react with the catalytic residues in the core domain. This Gln43 is 
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-bisphosphate (manual fitting followed 
-chain and phosphosugar 
 
 leishmanial PMM shows 
close proximity to C2 of 
phosphate (Gln43 N2 is only 2.3 
mannose 1-
, it would clash with the 
mannose 
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replaced by a strictly conserved serine in PMMs, and no steric 
hindrance is observed. This amino acid substitution is likely to be 
responsible for the strict specificity of APGM towards α-glucose 1-
phosphate. 
In addition, the crystal structure of human PMM1 with α-mannose 1-
phosphate was proposed to represent the first encounter state of the 
ligand with the enzyme (Silvaggi et al., 2006). The cap domain is 
found in an open conformation, and the residues engaged in the 
interactions with the ligand are mainly from the cap domain. In this 
structure, the hydroxyl group at C2 of the pyranose ring is H-bonded 
to Arg132, Asn137 and Asp190. The corresponding residues in APGM 
are Arg128, Ala133 and Asn181. The substitution of Asn to Ala affects 
the enzyme-substrate interactions, as no hydrogen bond can be 
established by Ala in APGM. Because the cap domain accounts for 
first step in substrate recognition and binding, the weaker 
interactions with α-mannose 1-phosphate in APGM may also 
contribute for its specificity towards α-glucose 1-phosphate.  
 
 
 
 
 
 
 
 
   α-Phosphoglucomutase 
71 
 
CONCLUSIONS 
 
Herein we presented the first high resolution structure of Lactococcus 
lactis α-phosphoglucomutase (APGM) with sulfate and glycerol 
bound at the active site. The enzyme cap domain is found in a tightly 
closed conformation. APGM is found to be a dimer in solution as well 
as in the crystal structure, which might be relevant for the enzyme 
efficiency; however the dimer interface differs from that found in 
eukaryotic PMMs. Despite low sequence identity, APGM shares 
structural homology with phosphomannomutases, although it can 
only utilize α-glucose 1-phosphate, but not its stereo-isomer α-
mannose 1-phosphate, like PMMs. Structural superposition of APGM 
and PMMs highlights their similarity and differences. A relevant 
difference seems to be the replacement of conserved Gly and Ser 
residues in PMMs by Ser41 and Gln43, respectively, in APGM, which 
adds steric constraints at the APGM active site.  
This study provides a framework towards engineering APGM to 
further understand its catalytic mechanism and strict substrate 
selectivity. The present lack of success in obtaining APGM crystals 
with ligands can be attributed to the crystallization conditions used, 
therefore new crystallization conditions facilitating complex 
formation of the APGM with ligands will have to be found.  
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3.1 INTRODUCTION 
 
Hyperthermophiles are able to withstand extreme temperatures and 
there is growing attention into the mechanisms they developed to 
survive thermal stress (Empadinhas and Da Costa, 2006; Trivedi et 
al., 2006). This knowledge may have potential applications as natural 
strategies to preserve activity of biomolecules will be very useful in 
both, medical industry and academic research, often aiming at 
unstable but of high interest human proteins (Mascellani et al., 2007). 
Moreover, fundamental mechanisms developed by organisms to 
adapt to very diverse environments is fascinating and still remains an 
open topic (Siddiqui and Thomas, 2008; Stetter, 1999). In recent 
phylogenetic analysis, Gonçalves et al. studied the evolution of the 
biosynthesis of di-myo-inositol-1,1´-phosphate (DIP), a marker of 
adaptation to hot environments (Gonçalves et al., 2012). DIP was 
found exclusively in a number of (hyper)thermophiles (Santos et al., 
2011). The genes involved in the biosynthesis of DIP were identified 
(Borges et al., 2006; Rodrigues et al., 2007) and the complete 
biosynthetic pathway was reconstituted in vitro (Rodionov et al., 
2007). Our attention was particularly attracted by the novel enzyme, 
CTP:L-myo-inositol 1-phosphate cytidylyltransferase (IPCT) / CDP-L-
myo-inositol myo-inositolphosphotransferase (also named di-myo-
inositol phosphate phosphate synthase and thus abbreviated DIPPS), 
that has two consecutive activities playing a key role in the 
biosynthesis of DIP. In most organisms, both genes coding for IPCT 
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and DIPPS activities are fused in a single gene, although separate 
genes are also found in a few organisms (Gonçalves et al., 2012). The 
bifunctional enzyme IPCT/DIPPS from Archaeoglobus fulgidus contains 
two domains with high homology to nucleotidyltransferases (N-
terminal IPCT) and CDP-alcohol phosphatidyltransferases (C-
terminal DIPPS). The recently published crystal structure of the 
cytoplasmic IPCT domain (Brito et al., 2011) shows the structural 
features typical of nucleotidyltransferase family (PF00483) and 
provides insights into the enzyme specificity for CTP substrate over 
other nucleoside triphosphates. However, structural characterization 
of the second domain, DIPPS, was hindered due to presence of 
predicted transmembrane helices and inherent difficulties in its 
expression and purification. In the present work we confirmed 
localization of the protein in the membrane fraction. The full length 
bifunctional protein was successfully overexpressed in Escherichia coli 
and we established the first protocol for IPCT/DIPPS purification. 
Pure and homogeneous protein of the full length IPCT/DIPPS was 
obtained allowing for crystallization experiments. Crystals were 
grown in crystallization with detergents diffracting to 4.5 Å. 
Moreover, the use of lipidic phases for crystallization resulted in 
crystals diffracting beyond 3 Å resolution and enabled solving the 
enzyme structure. To our knowledge this is the first report of 
crystallization and structure of a member of CDP-alcohol 
phosphatidyltransferase family (PF01066), which is a large family of 
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integral membrane proteins, including a number of enzymes 
involved in lipids biosynthesis and present in all domains of life. 
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3.2 PRODUCTION AND CRYSTALLIZATION OF 
IPCT/DIPPS 
 
3.2.1 MATERIAL AND METHODS 
 
3.2.1.1 CLONING, EXPRESSION AND PURIFICATION 
The gene AF_0263 was amplified from Archaeoglobus fulgidus DSM 
4304 chromosomal DNA using forward primer 
TGCCCCCGGGATGATAAATGTTGACGGAGAATAC and reverse 
primer TATGAGCTCTTTAGAAACCAAAACAGCAAGTAAAG. 
The gene was cloned into pET52b(+) vector using XmaI and SacI 
restriction sites which incorporate an N-terminal StrepII-tag and C-
terminal 10xHis-tag into the expressed protein. The construct for 
expression starts with the protein sequence MINVDG, where M 
corresponds to 55th residue of the translated AF_0263 gene. The full 
sequence of the expressed gene is given in the Appendix 1.  
The protein was expressed in E. coli strain C43 DE3 grown in terrific 
broth (TB) medium. On the day of expression 1% of an overnight 
culture was used to inoculate fresh medium with 100 µg ml-1 
ampicillin. The cells were grown at 37˚C with mixing at 200 rpm. 
When the OD600nm reached 1.0 (in about 3 – 3.5 h) the temperature was 
lowered to 30˚C and expression of the recombinant protein was 
induced by addition of 0.5 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG). Additional 50 µg ml-1 of ampicillin was 
added 3 h post-induction and cells were harvested 6 h post-induction 
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with OD600nm often reaching over 4.0. The biomass was harvested by 
centrifugation at 4000g for 20 min. The cell pellet was frozen in liquid 
nitrogen and stored at -80˚C. If the growth was performed in a 
fermentor then pH was controlled at 7.4, in addition to the phosphate 
buffer already present in the TB medium.  
All the steps of cell disruption and purification were performed at 
4˚C. In the usual purification the cells were disrupted in continuous 
flow cell disrupter in a buffer containing 50 mM sodium citrate, 50 
mM sodium phosphate, 200 mM NaCl, 5% glycerol, 100 mM sucrose, 
protease inhibitor cocktail tablet (SIGMAFAST from Sigma-Aldrich, 
use following the supplier recommendation), 1 mM 
ethylenediaminetetraacetic acid (EDTA), 0.5 mM 
phenylmethanesulfonylfluoride (PMSF), 2 mM β-mercaptoethanol 
(final pH 7.5 at 4˚C). E. coli membranes were isolated from cleared cell 
lysate (30 min centrifugation at 10000g) obtained from 30 l 
fermentation by ultracentrifugation at 200000g for 2 h. The protein 
was solubilized from resuspended E. coli membranes in the final 
volume of 200 ml by gentle stirring at 4˚C for 2 h in the presence of 
0.7% (w/v) DDM (Anagrade; Affymetrix) or 2% (w/v) Triton X-100 
(protein grade; Merck). Besides detergent the solution used for 
solubilization contained 20% glycerol, 1 M NaCl, 50 mM phosphate 
buffer, 50 mM imidazole, 100 mM sucrose, 2 mM β-mercaptoethanol 
and 1 mM MgCl2 (final pH 7.4 at 4˚C). The insoluble fraction after 
solubilization was separated by 1 h centrifugation at 100000g. The 
supernatant was loaded on three 5 ml HisTrap HP columns (GE 
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Healthcare) connected together. After loading the sample the 
columns were extensively washed with 20 – 40 column volumes of 50 
mM phosphate buffer, 50 mM imidazole, 10% glycerol, 1 M NaCl 
(final pH 7.4 at 4˚C). In the following washing step with 110 mM 
imidazole (otherwise buffer composition as in the wash buffer) was 
carried out with about 10 column volumes or until absorbance at 280 
nm reached baseline. The protein of interest was eluted in a step 
elution with 500 mM imidazole, 50 mM phosphate buffer, 10% 
glycerol, 300 mM NaCl, 1 mM MgCl2 (final pH 7.4 at 4˚C). 
Immediately after elution the sample was supplemented with 1 mM 
β-mercaptoethanol. The washing and elution buffers contained 
additionally one of the following detergents: 0.1 - 0.2% Triton X-100 
(Merck, protein grade), 0.05% DDM (Affymetrix, Anagrade). The 
sample was concentrated to 20 mg ml-1 in centrifugal filter unit with 
membrane of 100 kDa molecular weight cut-off. The protein behaves 
well during the concentrating step as long as the buffer contains at 
least 300 mM NaCl. In some cases the buffer was exchanged in the 
size exclusion chromatography to 10 mM CHES pH 9.5, 500 mM 
NaCl, 1 mM MgCl2, 1mM β-mercaptoethanol and the respective 
detergent used in purification.  
When protein sample was needed in the presence of a different 
detergent than the one used for membrane solubilization, the 
detergent was exchanged while the protein was bound to HisTrap 
column and washed in buffer containing the detergent of choice. 
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3.2.1.2 HOMOGENEITY TESTS  
Homogeneity tests were performed by diluting 10 times the initial 
protein sample at 27.5 mg ml-1 (with 0.5% Cymal-5 i.e. 2 times the 
critical micelle concentration, CMC) with variety of detergents at 
concentrations about two times higher than their CMC. The buffer 
besides the detergents tested contained 20 mM CHES pH 9.5, 500 mM 
NaCl, 10% glycerol, 1 mM MgCl2, 1 mM tris(2-
carboxyethyl)phosphine (TCEP). The samples were incubated at 20˚C 
for 6 days followed by size exclusion chromatography (Superdex 200 
5/150 GL, GE Healthcare) to assess the effect of the detergents on the 
sample homogeneity. It is worth to note that the incubated samples in 
addition to the tested detergent contained also Cymal-5 from the 
initial protein sample at 0.05%, which corresponds to concentration 
five times lower than its CMC. Thus, the protein was incubated in a 
mixture of detergents. Some of the samples showed precipitation 
after 6 days incubation at 20˚C, so these samples were centrifuged 
and the supernatant was also analyzed by SEC.  
 
3.2.1.3 CRYSTALLIZATION “IN DETERGENT”  
Initial screening of the crystallization conditions was performed with 
Cartesian Mini-Bee nano-robot at 20˚C using 13 crystallization 
screenings (over 1248 conditions). The vapor-diffusion crystallization 
with sitting drops was prepared by mixing 200 nl of protein sample 
(at concentration 20 mg ml-1 in buffer containing 500 mM imidazole, 
50 mM phosphate buffer, 10% glycerol, 300 mM NaCl, 1 mM MgCl2, 
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1mM β-mercaptoethanol and tested detergent) and 200 nl of reservoir 
solution. For each crystallization condition three crystallization drops 
were set up, each one containing protein sample in the presence of 
different detergent. The detergents tested initially included DDM 
(0.025%), Triton X-100 (0.25%), DM (0.2%) and OG (0.8% in mixture 
with mixture with 0.16% Triton X-100). 
 
3.2.1.4 DATA COLLECTION AND PROCESSING  
The weakly diffracting IPCT/DIPPS crystals obtained in the presence 
of Triton X-100 were measured at Swiss Light Source (SLS) beamline 
PXIII. Data were processed with XDS (Kabsch, 2010) and scaled with 
Scala (Evans, 2011). Molecular replacement was performed with 
Phaser (McCoy et al., 2007). The details are presented in Table 3.2. 
 
  3.2.2 RESULTS AND DISCUSSION 
 
The IPCT/DIPPS was cloned into vector pET52b(+) and expressed in 
E. coli C43 DE3 strain grown in terrific broth medium. The E. coli 
strain C43 DE3 gave better expression as compared with other tested 
strains such as C41 DE3, Rosetta and Bl21 DE3. Increased expression 
level was obtained when E. coli C43 DE3 cells were transformed with 
the additional plasmid encoding for rare E. coli codons. However 
higher expression yield was accompanied by extensive protein 
degradation and thus the latter was not used.  
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The full length IPCT/DIPPS was purified from 
protein was solubilized in Triton X
immobilized metal ion affinity chromatography
protein was obtained by minimizing the 
addition of high salt concentration 
wash buffer of immobilized metal ion 
Importantly, the protein construct with 
resulted in a strong binding of the protein to the HisTrap column 
allowing removal of contaminating proteins
(Figure 3.1). The protein was elu
imidazole concentration from 110 m
yield of purification was 2 – 4 mg per 
 
Figure 3.1 Coomassie blue stained SDS-PAGE 
(left) and His-tag specific InVision, Invitrogen
membrane, P – pellet after membrane solubilization, 
unbound fraction, W1 - wash with 50 mM imidazole, 
4 – eluted fractions with 500 mM imidazole. 
 
E. coli membranes. The 
-100 or DDM and purified using 
. Good purity of the 
ionic interactions with 
(1 M NaCl) in both loading and 
affinity chromatography. 
the deca-histidine tag 
 with 110 mM imidazole 
ted in one step, increasing the 
M to 500 mM. The usual protein 
one liter of growth medium.   
 
of fractions from purification of IPCT/DIPPS 
 (right). Lanes contain fractions: M – 
S – sample applied on HisTrap, F – 
W2 – wash with 110 mM imidazole, E1-
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Optionally, a size exclusion chromatography was used as the final 
polishing step of purification. Depending on the batch of purification 
0 - 50% of the protein elutes in the void volume. However, the pool of 
non-aggregated fractions is stable and homogenous over time.  
Detergents forming small micelles are assumed to expose more of the 
hydrophilic regions of membrane proteins which are predominantly 
involved in formation of crystal contacts (Bill et al., 2011; Kunji et al., 
2008). Thus smaller detergent micelles may promote formation of 
well ordered crystals (Ostermeier and Michel, 1997; Stroud, 2011). On 
the other hand the smaller detergent micelles are known to stabilize 
membrane proteins less effectively, leading to protein aggregation 
and precipitation. Monodispersity of the protein is often mentioned 
as one of the important parameters promoting crystallization (Berry 
et al., 2006; Geerlof et al., 2006; Proteau et al., 2010).  
In order to identify the detergents that effectively stabilize the protein 
over time (required for its crystallization) but also form small 
micelles, the impact of thirty detergents on IPCT/DIPPS 
monodispersity was tested by SEC (Table 3.1). Six out of thirty 
protein samples precipitated after incubation at 20˚C for six days. 
However, the samples of protein solubilized with n-octyl-β-D-
thioglucopyranoside (OTG) and n-octanoylsucrose, after spinning 
down the precipitation, appear to be only minimally aggregated. 
Thus it is not clear whether the observed white precipitate is due to 
protein precipitation or a result of progressive detergent degradation. 
In contrast, the samples that precipitated with octanoyl-N-
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methylglucamide (MEGA-8), cyclohexylpropanoyl-N-
hydroxyethylglucamide (C-HEGA-9), octanoyl-N-
hydroxyethylglucamide (HEGA-8), did not show any absorbance at 
280 nm after SEC, an indication that all the protein had precipitated. 
 The protein appears to be monodisperse in the detergents commonly 
used for membrane protein purification, as for example n-dodecyl β-
D-maltoside (DDM) and Triton X-100. Among the detergents forming 
small micelles and stabilizing the IPCT/DIPPS protein, are 
lauryldimethylamine-N-oxide (LDAO) and n-decyl β-D-maltoside 
(DM). In addition, two of the detergent series with cyclic 
hydrophobic chain, cyclohexyl-1-pentyl-β-D-maltoside (Cymal-5) and 
4-cyclohexyl-1-butyl-β-D-maltoside (Cymal-4) stabilize the protein 
well. Both detergents are characterized by small micelles and may 
also be suitable for crystallization. Interestingly, the detergents of the 
glucoside and maltoside detergent series with short hydrocarbon 
chains formed by 9 or 8 carbon atoms appear to be less effective than 
their counterparts in the thioglucoside and thiomaltoside series, 
which are also characterized with lower CMC values. 
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Table 3.1 Monodispersity tests of IPCT/DIPPS in various detergents. Samples were 
incubated for six days at 20˚C and analyzed by size exclusion chromatography (SEC). 
Classification of aggregation level: none, <10% (*), 10 – 50% (**), >50% (***). The precipitated 
samples were centrifuged and supernatant was also analyzed by SEC; if no absorbance at 280 
nm was observed, it is assumed that the entire protein sample precipitated (-). The SEC 
profiles and the abbreviations of detergent names are included in Appendix 3. 
Detergent After 6 days: 
precipitation (P), clear (C) 
 Aggregation 
DDM C  * 
Triton X-100 C  none 
DM C  none 
LDAO C  none 
Cymal-5 C  none 
NG C  ** 
OTG P  * 
OG C  *** 
Cymal-3 C  * 
MEGA-8 P  - 
CHAPS C  * 
CHAPSO C  none 
C-HEGA-9 P  - 
HEGA-8 P  - 
C-HEGA-8 C  * 
DTM C  * 
Cymal-4 C  none 
OTM C  * 
Fos-Choline-10 C  none 
Fos-Choline-9 C  *** 
Fos-Choline-8 C  *** 
C12E8 C  * 
ZWITTERGENT 3-12 C  * 
DDAO C  ** 
n-Octanoylsucrose P  * 
ZWITTERGENT 3-10 C  *** 
HEGA-10 C  * 
C8E5 C  *** 
NTG C  * 
HTG P  *** 
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The initial crystallization trials yielded a hit with the nuclear receptor 
- ligand binding domain crystallization screen (Molecular 
Dimensions) in the A5 condition containing 9% PEG 8000, 100 mM 
Tris pH 8.0 (Figure 3.2a). The protein sample used in this screening 
was applied directly after elution from the HisTrap column in the 
presence of 0.2% Triton X-100 and addition of the 1% n-Octyl-β-D-
Glucopyranoside. The 15 µm crystals diffracted very weakly at the 
European Synchrotron Radiation Facility (ESRF) synchrotron source 
at 30 Ả (Figure 3.2a). Upon extensive optimization of the 
crystallization conditions, hexagonal plate crystals and similar to 
hexagonal bipiramides, which however have cut off the two apices, 
were obtained with IPCT/DIPPS protein sample solubilized in Triton 
X-100 (Figure 3.2b-d). These crystals were obtained by vapor-
diffusion method in hanging drop with reservoir solution composed 
of 18% PEG 5000MME, 1 M NaCl, 100 mM BisTris pH 6.5 and mixed 
with a 1:1 ratio (volume) with protein sample. Larger crystals, up to 
300 µm were grown in drops where additionally one volume of water 
was added to initial drop formed with one volume of protein and one 
volume of reservoir. Interestingly, other IPCT/DIPPS batches 
showing some protein aggregation and not subjected to SEC 
purification still yielded crystals of similar diffraction quality. 
However, the diffraction of the crystals in all cases varied 
significantly even within the same crystallization drop. The crucial 
factors for crystallization appear to be high NaCl concentration. In the 
presence NaCl at concentrations lower than 700 mM in the 
  
crystallization condition the crystals 
higher NaCl concentrations decrease nucleation and impr
diffraction. On the other hand concentration of PEG 5000MME over 
20% appears to deteriorate the resolution limit to which crystals 
diffract. Addition of DIP at 25-50 m
was also used to yield better diffracting crystals.
 
Figure 3.2 Crystals of IPCT/DIPPS obtained in the presence of Triton X
Initial crystals obtained in the presence of PEG 8000. (b
optimization in the presence of PEG 5000MME
 
Crystals obtained in PEG 5000MME 
4.5 Å at synchrotron sources but with anisotropic diffraction and 
often not sufficient quality to be processed successfully. One dataset 
was processed up to 6.6 Å (Table 3.
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diffraction become worse. While 
ove 
M into the crystallization drop 
 
 
-100 (examples). (a) 
-d) Crystals obtained upon 
. 
(Figure 3.2c-d) diffracted up to 
2).  
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Section 3.3.1 of this chapter describes crystallization in lipidic 
mesophases and structure solution of IPCT/DIPPS. This structure was 
also used as a search model for molecular replacement phasing of 
data collected at 6.6 Å from crystals obtained in the presence of 
detergent described in this section. The protein in the presence of 
detergent crystallized in the hexagonal space group P6522 with two 
molecules in the asymmetric unit, while the crystals grown in lipidic 
phases belonged to the orthorhombic space group P21212 with one 
molecule in the asymmetric unit (Table 3.2). In the presence of two 
IPCT/DIPPS molecules in the asymmetric unit the solvent content of 
the crystal was 73.4%.  
The molecular replacement solution has no clashes in the crystals 
packing. Moreover, a continuous electron density for the secondary 
structure elements is observed, including the transmembrane helices 
of DIPPS domain (Figure 3.3). However, the low resolution of this 
data set hinders refinement of the structure. 
The obtained solution indicates that the overall interdomain 
geometry of IPCT/DIPPS is preserved in the two different methods of 
membrane proteins crystallization, in lipidic mesophases and in 
detergent. The dimer interface is formed through the DIPPS domain. 
 
 
 
  
Figure 3.3 Molecular replacement solution with data
crystallization with Triton X-100. The protein polypeptide
Shown fragment of the DIPPS transmembrane domain illustrates 
density for the secondary structure elements in the view parallel to the expec
surface (left) and across the expected membrane (right).
replacement was at 6.6 Å resolution and the electron density cut
1 RMSD. 
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 collected from crystal obtained in 
 chain is represented by Cα atoms. 
the continuous electron 
ted membrane 
 The data used in molecular 
-off shown in the figure is at 
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3.3 STRUCTURE DETERMINATION OF THE 
BIFUNCTIONAL ENZYME IPCT/DIPPS  
 
3.3.1 MATERIALS AND METHODS 
 
3.3.1.1 CRYSTALLIZATION IN LIPIDIC PHASES 
The sample of IPCT/DIPPS was subjected to lipidic sponge phases 
crystallization screening (Molecular Dimensions) with 48 different 
conditions following the manufacture´s protocol. The crystallization 
drops were equilibrated against the solution which yielded crystals in 
detergent (described in section 3.2.2) and in one trial this solution was 
also added to the crystallization drop accounting for about 30% of its 
volume. Crystals were obtained in about 16 out of the 48 conditions 
of the screening indicating that lipidic phases may be a suitable 
medium for crystallization of IPCT/DIPPS (Figure 3.4).  
Protocols for further crystallization screening and up-scaling of the 
crystallization in lipidic mesophases were carried out by the group of 
Valentin Gordeliy (IBS, Grenoble). These efforts resulted in crystals of 
100 µm that diffracted beyond 3 Ả. 
 
  
Figure 3.4 Examples of IPCT/DIPPS crystals obtained 
sponge phase crystallization screen (Molecular Dimensions).
 
3.3.1.2 DATA COLLECTION AND PROCESSING
 
Diffraction data were collected from crystals obtained in lipidic 
mesophases at ID23-1 and ID23
Synchrotron Radiation facility (ESRF, Grenoble, France). The data 
were integrated to 2.85 Å (Rmerge at the border is 59%, I/σ
Data collection and processing, phasing and 
refinement were performed by the group of Valentin Gordeliy
3.2). 
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in some conditions of the lipidic-
 
 
-2 beamlines of the European 
(I) is 1.9). 
crystallographic 
 (Table 
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Table 3.2 Data collection and processing statistics of IPCT/DIPPS. 
 
Crystallization method  “In detergent”  Lipidic mesophase  
X-ray source SLS beamline, PXIII  
Wavelength (Å) 1.000  
Temperature (K) 100  
Detector PILATUS 2M-F  
Rotation per image (°) 0.2  
Space group P6522 P21212 
Unit-cell parameters (Å) a = b = 107.53, c = 609.23 
 
a=41.33, b=107.65, c= 
123.22 
Resolution range (Å) 54.72 - 6.60 (6.96 – 6.60) 40.67 - 2.852    
Total No. of reflections 72653 (10724)  
No. of unique reflections 4554 (630) 13318 (2415) 
Completeness (%) 99.8  (100.0) 97.93 (91.0) 
Average multiplicity 16.0 (17.0)  
Average I/σ(I) 8.2 (1.6)  
Rpim (%) 5.0 (46.0)  
Overall B factor (Å2) - 60.98 
Statistics on refinement    
Resolution (Å) - 2.85 (3.07-2.85) 
No. reflections - 13318 
Rwork / Rfree (%) - 24.7/30.6 
R.m.s. deviations   
    Bond lengths (Å) - 0.003 
    Bond angles () - 0.631 
Values for the higher resolution shell are given in parentheses. 
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3.3.1.3 PHASING AND CRYSTALLOGRAPHIC REFINEMENT 
Initial phases were obtained by molecular replacement using the 
crystallographic structure of the IPCT soluble domain (PDB ID 2XME, 
Brito et al. 2011) as a starting model. Search for α-helical fragments 
resulted in establishing the position of five transmembrane α-helices. 
Refinement of the structure fragments improved the electron density 
maps, allowing the identification of the sixth transmembrane helix 
and two α-helices parallel to the membrane plane. The 
crystallographic model was further refined until final R-factors of 
24.7% (Rfree of 30.6%). The structure contains all the residues of the 
transmembrane domain except for the disordered loops (291 - 298 
and 430 - 440) and C-terminal lysine (numbering following UniProt 
entry O29976). 
  
3.3.1.4 MUTAGENESIS AND ACTIVITY TESTS 
After obtaining the structure of IPCT/DIPPS, mutagenesis were 
attempted in order to elucidate the role of amino acid residues within 
the putative active site and potentially involved in substrate binding. 
Primers for mutagenesis were designed using QuikChange primer 
design web tool. The point mutations were introduced using the 
QuikChange I site-directed mutagenesis kit (Agilent Technologies). 
All point mutations were confirmed by sequencing using the 
StabVida sequencing service (Caparica, Portugal). The mutants were 
cultured following the protocol described for the wild type (section 
3.2.1.1).  
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The activity tests were performed by team of Prof. Helena Santos 
from Cell Physiology & NMR Laboratory (ITQB-UNL, Oeiras) 
including Ana M. Esteves and Nuno Borges. Cells were resuspended 
in 50 mM Bis-Tris propane (pH 8.0) containing 5% glycerol and 100 
mM NaCl, and disrupted in a French press. Cell debris was removed 
by centrifugation (10000g, 15 min, 4˚C) and the supernatant was used 
to measure IPCT/DIPPS activities. Reaction mixtures (0.3 ml) 
containing 25 mM Bis-Tris propane (pH 8.0), 10 mM MgCl2, 2.7 mM 
CTP, 7 mM L-myo-inositol 1-phosphate, and cell extract (0.9 mg of 
total protein) were incubated at 85˚C and samples were collected after 
30 minutes. The reactions were stopped by placing the sample on ice. 
The metal ions were chelated with ethylenediaminetetraacetic acid 
(EDTA) and the amounts of the product and reaction intermediate 
were assessed using 31P NMR using diglycerol-phosphate as an 
internal concentration standard. 
  
3.3.2 RESULTS AND DISCUSSION 
 
3.3.2.1 X-RAY STRUCTURE OF IPCT/DIPPS 
The final model comprises one IPCT/DIPPS molecule with 396 amino 
acid residues (from one polypeptide chain), four lipophilic fragments 
of lipids and one Mg2+. The IPCT/DIPPS molecule is composed of two 
domains (Figure 3.5).  
 
  
Figure 3.5 IPCT/DIPPS dimer. Secondary structure shown in ribbon representation
monomer colored; yellow to green – IPCT, cyan to red 
crystallographic symmetry polypeptide chain 
helices and six transmembrane helices (TM1-TM
ion. The secondary structure elements were assigned with DSSP 
This figure and others in this chapter were drawn with CCP4
unless stated otherwise. 
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. One 
– DIPPS, and the related by 
A´ in grey. The labels indicate two connector 
6); the grey sphere indicates putative Mg2+ 
(Kabsch and Sander, 1983). 
MG (McNicholas et al., 2011) 
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The cytoplasmic IPCT domain (Figure 3.6a), as described in detail by 
Brito et al. (2011), has a fold typical of cytidylyltransferases somewhat 
similar to the dinucleotide-binding Rossmann fold (Rao and 
Rossmann, 1973). The central part consists of a seven-stranded mixed 
β-sheet (β1, β4, β5, β6, β8, β12 and β11). It is flanked on one side by a 
two-stranded antiparallel β-sheet β7 and β13 (which together with β2 
and β3 form an interface to the connector helix 1) and helices α1, α2, 
α4. On the other side, where the active site is located, there is a two-
stranded antiparallel β-sheet, β9 and β10, and helices α3, α5, α6. The 
IPCT domain of the bifunctional enzyme structure is very similar to 
the previously published X-ray structure of the IPCT domain alone 
determined at 1.9 Å resolution (Brito et al., 2011), with a RMSD for all 
Cα atoms of 0.6 Å. The C-terminal of the IPCT alone was truncated at 
amino acid residue 286 and the crystallographic model of IPCT lacks 
the last 10-12 residues. The major difference is the inclusion of the 
connector helix 1 in the bifunctional construct, which covers the 
hydrophobic face of the β-sheet formed by β7 and β13. This connector 
helix 1 prevents the interactions mediated through this short β-sheet 
observed in the truncated form of IPCT, which led to the formation of 
an apparent dimer. 
 
  
Figure 3.6 Secondary structure representation of (a) IPCT domain and (b) dimer formed by 
DIPPS domains (view perpendicular to the membrane plane
 
 IPCT/DIPPS 
103 
 
 
).  
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The cytoplasmic IPCT domain is connected to the membrane DIPPS 
domain via two helices nearly parallel to the membrane (connector 1 
and 2) and a flexible loop (Figure 3.5). DIPPS domain comprises six 
transmembrane helices (Figure 3.6b), four of which (TM2, TM3, TM4, 
TM5) resemble a four-helix bundle fold (Kamtekar and Hecht, 1995). 
The transmembrane helices and connector helix 2 form a hydrophilic 
cavity in the central part of the domain, which widely opens towards 
the cytoplasm. One of the loops (between TM2 and TM3) located at 
the entrance of this cavity comprises amino acids 369-373, and in 
spite of the high thermal motion parameters shown by these residues 
(average B-factor for Cα atoms is 84 Å2), it is visible in the electron 
density maps. In contrast, the two additional loops that should also 
be placed at the entrance could not be modeled, likely due to their 
flexibility. One of the loops (residues 291 - 298) is situated between 
the connector helix 1 and connector helix 2, and the other loop 
(residues 430 - 440) connects TM4 and TM5.  
 
3.3.2.2 QUATERNARY STRUCTURE 
The IPCT/DIPPS molecule, present in the crystal asymmetric unit, 
forms extensive contacts with another molecule related by 
crystallographic symmetry (operator -x+2,-y+1,z) (Figure 3.5). This 
interface is entirely formed by interactions between the two DIPPS 
domains, involving mainly the hydrophobic residues sited at TM3, 
TM4 and TM6 (Figure 3.7). Further stabilization is achieved by 8 
hydrogen bonds and 2 salt bridges established among residues 
  
located near the cytoplasmic membrane surface and in the 
extramembrane region. The interf
surface of 1936 Å2 and the CSS value of 1 
that the interface has an essential role in complex formation 
and Henrick, 2007). 
 
Figure 3.7 IPCT/DIPPS dimer interface. Residues involved in the interface formation shown 
in sticks representation. One IPCT/DIPSS molecule is displayed in cyan, while the 
symmetry-related molecule is colored yellow. 
they belong to. The other atoms are colored: O 
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ace area extends over a large 
assigned by PISA implies 
(Krissinel 
 
C atoms have the same color as the molecule 
– red, S – green, N – blue. 
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3.3.2.3 INTERFACE BETWEEN IPCT AND DIPPS DOMAINS 
IPCT and DIPPS domain are found as separate enzymes in some of 
hyperthermophilic prokaryotes, like Thermotoga maritima and 
Pyrolobus fumarii (Gonçalves et al., 2012). The fusion of these two 
activities in the bifunctional enzyme from Archaeoglobus fulgidus 
reported here raises an interesting question about possible 
cooperativity between the two domains catalyzing consecutive steps 
in the biosynthesis of DIP. 
The connector helix 1 is an integral part of the IPCT domain and is 
also present in a number of other nucleotidyl transferases. 
Comparison with 25 similar structures from Dali search (Holm and 
Rosenström, 2010) indicates that the position of this helix is highly 
conserved (Figure 3.12), covering the hydrophobic surface of strands 
β2, β3 and β7, β13 from IPCT. 
The crystal structure shows that IPCT domain binds to the solvent 
exposed edge of the DIPPS domain (Figure 3.8). Interactions at this 
interdomain region involves amino acid residues from connector 
helix 1, short two-stranded β-sheet (β2, β3) and the helix α1 (IPCT) 
with connector helix 2 and TM2 (DIPPS domain). The interface 
extends over only 479 Å2 and is stabilized by a few hydrophobic 
contacts and 4 hydrogen bonds. The CSS score of 0 in PISA server for 
interface between IPCT and DIPPS implies that it can be easily 
dissociated and seems to be a result of crystal packing only. 
Additionally, low conservation of the residues involved in this 
interface formation may indicate its non-essential character. 
  
Figure 3.8 The interface between the IPCT and DIPPS domain. The residues involved in the 
interaction are represented as sticks. The C atoms and 
domain and coral - IPCT domain. H-bonds between domains indicated with 
other atoms are colored: O – red, S – yellow, N –
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ribbons are colored cyan - DIPPS 
dashed line. The 
 blue. 
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3.3.2.4 POSITION OF DIPPS DOMAIN IN THE MEMBRANE 
The DIPPS domain, comprising six transmembrane helices, forms an 
integral part of the cytoplasmic membrane. The  position of these six 
α-helices in the membrane was predicted by PPM web server 
(Lomize et al., 2012) and is shown in Figure 3.9a. In this model all the 
extramembrane loops are localized on the cytoplasmic side of the 
membrane. In addition, the extended transmembrane helices TM1, 
TM2, TM4 and the C-terminus of TM6 are partially localized in the 
cytoplasm. Interestingly, TM2 has a kink introduced by Gly358, 
which coincide with the membrane surface.  
The loops at the opposite side of the membrane appear to be 
embedded entirely inside the membrane, with predominantly 
hydrophobic residues and only a few charged ones in the proximity 
of the membrane surface, which could interact with the hydrophilic 
part of the phospholipid bilayer. This model seems to be well justified 
by the electrostatic surface of the domain shown in Figure 3.9b. 
 
 
 
  
Figure 3.9 Predicted position of IPCT/DIPPS in 
electrostatic surface of the protein (b). IN and OUT labels indicate respectively cytoplasmic 
and extracellular side of the membrane. Molecular surface: negatively charged 
positively charged - blue. The figures were draws using PyMOL and the position of the 
protein in the membrane was calculated using PPM server 
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the membrane (a) and corresponding 
- red, 
(Lomize et al., 2012). 
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Connector helix 1 has a partially 
hydrophobic side faces the hydrophobic surface of β
of IPCT, while the side-chains of 
directed towards the surface of the membrane
distance to predicted surface of about 
Connector helix 2 passes through the predicted surface of the 
membrane in a slightly sloped angle
beginning of this helix, from Ile299 
membrane and the positively charged residues of this 
pointing towards the hydrophilic membrane surface. 
 
Figure 3.10 Helical wheel representation of connector
around the wheel indicate the approximate 
membrane. The membrane position of connector helix 2 (b) is representative for the fragment 
embedded in the membrane, Ile299 to Ser308. 
 
 
amphipathic character, its 
-sheet (β7, β13) 
positively charged residues are 
 (Figure 3.10) with Cα 
10 Å. 
 from parallel orientation. The 
to Ser308, is embedded inside the 
segment are 
 
 
s helix 1 (a) and helix 2 (b). Lines 
position of the helix with respect to the 
   IPCT/DIPPS 
111 
A negatively charged patch is observed at the center of IPCT/DIPPS 
dimer (Figure 3.9b), formed by six glutamate residues at TM4 and 
inter-connecting loop TM4-TM5, (numbered 419, 424 and 427). The 
negative charge at the cytoplasmic end of TM4 protrudes large part of 
the helix out of the membrane into the cytoplasm and results in about 
7 Å distance of TM4 (at Thr402) away from the calculated 
extracellular surface of the membrane.  
Also the other side of the hydrophilic cavity scaffold formed by TM1 
and TM2 (Figure 3.9a) protrudes from the membrane into the 
cytoplasm embraced by the amphipathic connector helix 2. This helix 
is predicted nearly parallel to the membrane surface and together 
with loop connecting to TM1 wraps around the TM2. The positions of 
TM1 and TM2 are 11.9 Å and 8.7 Å (at Cα of Leu337 and at Cα of 
Pro344) away from the calculated extracellular membrane surface. 
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3.3.2.5 CRYSTAL PACKING IN LIPIDS AND IN DETERGENT 
The IPCT/DIPPS three-dimensional structure obtained from crystals 
grown in the lipidic phase is formed by layers of DIPPS domain, 
interconnected with layers of IPCT domains, which are responsible 
for the majority of the crystal contacts (Figure 3.11). The 
intermolecular contacts between the DIPPS dimers are limited to 
weak interactions. One involves residues at the end of connector helix 
2 (Ala314, Ile315, Lys318) with the loop between TM5 and TM6 (Ala 
458, Ile459) of the neighbor molecule, which form two hydrogen 
bonds and two hydrophobic contacts. Moreover, these hydrophobic 
interactions appear to be extended on both sides of the loop via two 
hydrocarbon chains (probably fragments of lipids) defined in the 
electron density. The other, involves hydrophobic interactions of 
Val481, Leu484, Ala485 and Val488, sited at the C-terminal ends of 
TM6 from two neighboring DIPPS dimers. .  
Interactions of the IPCT domains are much more extensive in the 
crystal lattice. Each IPCT domain interacts with DIPPS domain of the 
same molecule (as described in section 3.3.2.3), three IPCT domains of 
the same layer and two IPCT domains of the neighboring layer. The 
strongest of these contacts is formed between IPCT domains of 
different layers. It comprises an interface area of 323.4 Å2 and the 
amino acid residues involved in H-bonding are located at α5 and 
loops between α3 and β6, β9 and β10, α6 and β12. 
In comparison with the crystal packing of crystals obtained in the 
presence of Triton X-100 (Figure 3.11; described in sections 3.2.1.3 and 
  
3.2.2) the crystal lattice of crystals from lipidic phase appears much 
more ordered. In both cases, the lattice
domains, with the layers linked only via cytoplasmic domains.
distance between adjacent layers of membrane domains 
Å in crystals from lipidic phase,
crystals grown in the presence of Triton X
irregular arrangement.  
 
Figure 3.11 Crystal packing of crystals obtained in lipidic mesophases (left) 
presence of Triton X-100 (right). The two domains are shown in different colors, IPCT 
DIPPS – cyan and the secondary structure represented 
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 and 46 Å (shortest distance) in 
-100, also showing a more 
 
and in the 
– coral, 
as ribbons.  
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3.3.2.6 HOMOLOGOUS STRUCTURES 
Analysis of IPCT homologous structures were addressed extensively 
by Brito et al., (2011). Briefly, the most similar structures found with 
Dali server (Holm and Rosenström, 2010) belong to the  
nucleotidyltransferase family with only 13 to 22% of sequence 
identity. The first hits are also structures of bifunctional enzymes 
with highest Z-score of 22 (PDB codes: 4aaw, 2ggq and 1hv9). The N-
terminal domain, N-acetylglucosamine-1-phosphate-
uridyltransferase, is also a nucleotidyl transferase. However, the 
second domain, glucosamine-1-phosphate-acetyltransferase, is 
unrelated to DIPPS and belongs to bacterial transferase hexapeptide 
family (PF00132). 
Superimposition of A. fulgidus IPCT structures previously 
characterized (PDB codes: 2xme and 2xmh, derived from two 
different crystal forms) with similar structures indicates that the C-
terminal helix is missing in the expressed construct, which here is 
named connector helix 1. The position of this helix appears to be 
conserved among related structures (Figure 3.12) and forming stable 
hydrophobic interactions with the core (Figure 3.10a).  
 
  
Figure 3.12 Structure conservation of IPCT domain and homologues. IPCT in cartoon rockets 
representation is colored according to structure conservation (as described by 
Rosenström, 2010) within 25 structures similar to IPCT obtained from Dali server 
Rosenström, 2010); red – high structure conservation, blue 
Figure was drawn with Jmol, part of the on-line tool for results analysis in DaliLite. PDB 
codes of structures included in the comparison: 2ggq, 4aaw, 2ggo, 3pkp, 1hv9, 3hl3, 1g95, 
1hm0, 3juj, 3juk, 1hm9, 2oi5, 1hm8, 1g97, 1fzw, 
2pa4, 1iim, 1mc3. 
 
The absence of connector helix 1 in the previous 
et al., 2011) resulted in exposure of 
sheet formed by β7 and β13. This hydrophobic surface
in formation of a strong crystal contact. 
present in the full-length IPCT/DIPPS 
strongly hydrophobic character of the 
with core of IPCT and conservation of the helix position among
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Holm and 
(Holm and 
– low structure conservation. 
2oi6, 1fxo, 2v0i, 1g1l, 1g23, 1g0r, 1g2v, 1mp5, 
IPCT structure (Brito 
the hydrophobic surface of β-
 was involved 
Similar crystal contact is not 
structure. Moreover, due to the 
connector helix 1 interaction 
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structures of nucleotidyl transferases
1 and formation of similar interface seems to be unlikely.
 The top hits of Dali search for the DIPPS domain 
protein kinase CheA from Salmonella enterica
for Cα 3.5 Å) and from Rhodobacter sphaeroi
for Cα 3.9 Å). CheA is histidine phosphotransfer domain that 
mediates response regulator phosphorylation in bacterial chemotaxis
(Bell et al., 2010; Mourey et al., 2001)
soluble protein and its α-helices distribution and connectivi
resembles that of TM2 – TM6 in 
conservation. The CheA helices corresponding to TM2 
four-helix bundle fold and an additional C
much like TM6 (Figure 3.13). 
Figure 3.13 Superimposition of DIPPS (gold) with CheA from 
Helices TM2 - TM5 of DIPPS resemble the four
shown in cylinder representation. Superimposition performed with Dali s
, the mobility of connector helix 
 
was a histidine 
 (PDB code: 1i5n; rmsd 
des (PDB code: 3kyj; rmsd 
 
. Unlike DIPPS, the CheA is a 
ty 
DIPPS, despite lack of sequence 
– TM5 form a 
-terminal helix is oriented 
 
Salmonella enterica (magenta). 
-helix bundle fold of CheA. Helices are 
erver. 
  
3.3.2.7 ACTIVE SITE OF DIPPS  
DIPPS catalyses transfer of L-myo
CDP-L-myo-inositol to another molecule of L
phosphate yielding the final product di
1´-phosphate, CMP and H+. The DIPPS domain belongs to the CDP
alcohol phosphatidyltransferase 
similarity and inclusion of the conserved sequence signature pattern 
DG(x)2AR(x)8G(x)3D(x)3D (Figure 3.
Asp360.  
 
Figure 3.14 Zoomed in view of DIPPS structure shows the amino
conserved sequence pattern of the CDP-alcohol phosphatidyltransferase family and 
conserved Asp357 coordinating the metal ion. The grey sphere indicates putative Mg
atoms are colored as in all the other figures: C 
nitrogen, unless indicated otherwise. 
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-inositol from its activated form, 
-myo-inositol-1-
-myo-inositol-1,3´-phosphate-
-
family based on the sequence 
14, Figure 3.15), starting at 
 
 acid residues from the 
2+. The 
– green, O – red, yellow – sulfur, blue – 
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This consensus sequence is likely to include some of the catalytic 
residues crucial in the transfer of the β-phosphoryl from the CDP-
alcohol donor. The X-ray structure of IPCT/DIPPS shows a putative 
magnesium ion site and two of these aspartate residues appear to 
coordinate Mg2+, with distances of 2.3 Å to Asp360 and 2.6 Å to 
Asp378. Additionally, the conserved Asp357 (2.4 Å to Oδ and 2.3 Å to 
O of the backbone) is also coordinated to Mg2+. The metal ion was 
shown to be required for the activity of the enzyme (Table 3.3) and 
thus should be involved in the catalytic mechanism. Here we assume 
that the metal ion indicates the position of the active site in the 
structure (Figure 3.16). The last residue of the consensus sequence, 
Asp382 is 4.3 Å away from Mg2+ ion, at the bottom of the catalytic 
pocket. 
The amino acid residues that are strictly conserved (Figure 3.15) in 
the enzymes with confirmed or putative DIPPS activity (Gonçalves et 
al., 2012; Figure 3.16) are likely to play a crucial role in the enzyme 
function and provide clues into the possible binding sites of the 
substrates.   
  
Figure 3.15 Amino acid sequence alignment
alignment (Geneious 6.0.3 software) based on IPCT and DIPPS sequences from 3
with confirmed or putative DIP production (Gonçalves et al., 2012)
the major branches of phylogenetic tree (Gonçalves et al., 2012)
is shown in Appendix 1. Black arrows indicate 
 IPCT/DIPPS 
119 
 
 of IPCT/DIPPS. Created with Geneious 
3 organisms 
. The sequences represent 
 and the complete alignment 
expressed construct beginning and domains 
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boundaries. Strictly conserved residues among all 
organisms) are displayed in bold. The secondary structure elements represented wit
arrows - β-strands and red tubes - α-helices were 
1983). 
 
Figure 3.16 DIPPS structure with the conserved residues 
(Figure 3.15) represented as sticks. The atoms are colored: 
blue. 
 
It is worth to mention that in the crystal structure the active sites of 
the IPCT and DIPPS domain do not face each other as one may expect 
for two enzymes involved in consecutive steps of the 
(Figure 3.17). This could be an effect of the crystal packing and
also not clear if there could be some rearrangement within the 
enzyme that will allow direct passage of the product of the IPCT 
domain into the active site of the DIPPS domain.
IPCT/DIPPS sequences (from 33 
h blue 
assigned with DSSP (Kabsch and Sander, 
 
among the enzymes producing DIP 
C – green, O – red, S – yellow, N – 
synthesis 
 it is 
 
  
 
Figure 3.17 Arrows indicate the accessibility towards the
IPCT domain is in ribbon representation (green) and superimposed with 
IPCT alone previously determined and shown in dark purple
citrate bound in active site (indicated with transparent purple surface)
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 active sites of IPCT and DIPPS. The 
the structure of 
 (2XMH, Brito et al., 2011) with 
. 
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3.3.2.8 PUTATIVE SUBSTRATE BINDING SITE 
The binding site of the substrate, L-myo-inositol 1-phosphate, in the 
DIPPS domain was probed with HEX docking server (Macindoe et 
al., 2010). The plausible solution was chosen based on the ligand 
fitting, its interactions and position with respect to the conserved 
residues and putative catalytic site (Figure 3.18).  
The modeled L-myo-inositol 1-phosphate accommodates the pocket at 
the bottom of the active site. The phosphoryl group of the substrate 
interacts with the conserved positively charged Arg305, and 
conserved Ser308 is 4.3 Å away from the phosphoryl group. Nearby, 
the conserved Gly358 introduces a kink into TM2 but also enables 
formation of the cavity to accommodate the substrate´s phosphoryl. 
The inositol ring forms hydrogen bonds with the strictly conserved 
Asn304, Arg443, Ser354 and Asp357. The hydroxyl group located on 
the C3 of the inositol ring, which is engaged in the reaction, forms H-
bond to conserved Asp357. In addition, Asp382 of the consensus 
sequence is 5.5 Å away from the hydroxyl.  
 
 
  
Figure 3.18 L-myo-inositol 1-phosphate docked into DIPPS represented as (a) cartoon 
representing α-helices and side chains of strictly conserved residues in sticks mode
der Waals surface of the binding pocket. In the figure (a) the C atoms of the s
colored in yellow. The other atoms are colored: 
white, P – magenta in (a) and orange in (b). Figure (a) 
et al., 2011) and (b) with PyMOL. 
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 (b) van 
ubstrate are 
C – green, O – red, S – yellow, N – blue, H – 
was drawn with CCP4MG (McNicholas 
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3.3.2.9 MUTAGENESIS 
The structure of IPCT/DIPPS provided the first atomic model for 
CDP-alcohol phosphatidyltransferase family. This model was used in 
an attempt to understand the role of some of the residues which 
might be involved in the catalytic mechanism of the enzyme. Single 
point mutations have been introduced into DIPPS domain as listed in 
Table 3.3 and their impact on the activity was measured. Detailed 
results of the activity tests can be found in Appendix 2. 
 
Table 3.3 Impact of the IPCT/DIPPS point mutations on the DIPPS activity. CSP – consensus 
sequence pattern of the CDP-alcohol phosphatidyltransferase family. Activity: moderate 
reduction – 80% - 30% of the WT activity, strong reduction – below 30% of the WT activity. 
Detailed results are presented in the Appendix 2. 
mutation activity  CSP localization 
S308A moderate reduction  connector helix 2 
S308M inactivation  connector helix 2 
D357A inactivation  TM2 
D357N strong reduction  TM2 
D360A inactivation yes TM2  
D360N inactivation yes TM2 
A364M strong reduction yes TM2 
R365M strong reduction yes TM2 
S371P strong reduction  Loop TM2-TM3 
D378A inactivation yes TM3 
D378N inactivation yes TM3 
D382A inactivation yes TM3 
D382N inactivation yes TM3 
R443A inactivation  TM5 
WT(-Mg2+)  inactivation   
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The residues tested by mutagenesis can be divided into three groups 
with respect to their sequence conservation. The group comprising 
the conserved consensus sequence pattern (CSP) of the family (Table 
3.3) may be the most critical for the reaction mechanism, 
independently from the substrate utilized by the enzyme. The second 
group of residues consists of residues strictly conserved within the 
sequences of known or putative DIPPS function as described by 
Gonçalves et al., 2012 (Figure 3.15). Some of these may be involved in 
the substrate binding. The third group of residues that are not strictly 
conserved and so their function may not be limited to the exact side 
chain properties and their role might be fulfilled by other similar (or 
not) residues. The positions of mutated residues in the structure are 
shown in the Figure 3.19. In further discussion, the conserved 
residues refer to the enzymes with confirmed or putative DIPPS 
activity (Gonçalves et al., 2012). The residues conserved in the CDP-
alcohol phosphatidyltransferase family are referred as consensus 
sequence pattern or CSP. 
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Figure 3.19 Residues mutated for activity assay 
corresponds to the effect on DIPPS activity; yellow 
strong reduction and red – inactivation. The atoms are colored: 
 
All the conserved aspartate residues located nearby the putative Mg
site, when mutated to alanine, inactivate the DIPPS enzyme (
3.19). However, all mutations of those residues to asparagines 
inactivate the enzyme, except Asp
activity. Effect of Asp357, Asp360
activity might be related to their role in coordination 
This metal ion was shown to be required for reaction and the activity 
assays were performed in the presence of 10
absence of metal ion the enzyme is inactive
might be a plausible explanation for the observed inactivation 
D357A, D360A/N, and D378A/N 
D357N.  
 
are shown as sticks. The color of the label 
– moderate activity reduction, orange - 
C – green, O – red, N – blue. 
2+ 
Figure 
357, which retains some basal 
 and Asp378 mutations on the 
to the Mg2+ ion. 
 mM MgCl2, while in the 
. Defective binding of Mg2+ 
of 
or severe decrease of activity of 
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The role of the Asp357 is likely to be beyond anchoring the Mg2+ ion. 
In fact this residue is not included into the CSP. However, it is well 
conserved in related protein sequences, including the five human 
enzymes belonging to CDP-alcohol phosphatidyltransferase family. 
As earlier discussed, this residue interacts with the docked L-myo-
inositol 1-phosphate. The H-bonding is to the hydroxyl located on C3 
of inositol ring, which is involved in the reaction of coupling with 
another L-myo-inositol 1-phosphate molecule activated with CDP. 
Preservation of basal activity for one of the mutants, D357N, suggests 
its role in positioning the substrate for reaction, which can still be 
partially maintained by asparagine, but abolished with alanine 
residue. 
The aspartate Asp382 (CSP) is located 4.2 Å away from Mg2+ and 5.5 
Å away from the docked L-myo-inositol 1-phosphate (Figure 3.18). 
Mutation of Asp382 to alanine or asparagine, inactivating DIPPS, 
suggests that Asp382 role might be not just positioning through H-
bonding of substrate, which might be still carried out by asparagine. 
At this initial stage it is assumed that Asp382 may perform some 
catalytic function.  
The binding mode of the L-myo-inositol 1-phosphate as obtained from 
docking (Figure 3.18) was probed with mutation of Ser308 of 
connector helix 1, located at the end of the putative substrate binding 
pocket. Position covered from the putative catalytic site by TM2 
suggests that the residue is not directly involved in catalysis. In our 
model this residue may be involved in the H-bonding to the 
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phosphoryl of L-myo-inositol 1-phosphate. Mutation S308A results in 
moderate reduction of DIPPS activity. We speculate that this may be 
a result of weakening of L-myo-inositol 1-phosphate binding due to 
lost of the H-bond between the substrate and Ser308 in the binding 
site. Introducing longer methionine residue, S308M, inactivates the 
enzyme possibly by partially filling in the phosphoryl pocket binding 
and thus interfering in L-myo-inositol 1-phosphate binding. 
Additionally, Ser308 is a strictly conserved residue in enzymes with 
DIPPS activity and thus it may well be important for interaction with 
substrate.  
The second serine residue tested is Ser371 located in the loop 
connecting TM2 and TM3 (residues 367 - 376). This loop contains 
Gly374 which is part of the consensus sequence pattern. In this 
particular enzyme there is also a second neighboring glycine, Gly375. 
Comparison with other sequences of the family shows that it is 
common to find additional glycine residues in this loop. Strict 
conservation of the Gly374 in the enzyme family may indicate the 
importance of flexibility of this loop for function. For mutagenesis we 
have chosen Ser371, which is not strictly conserved and may appear 
as threonine or glutamine in the DIPPS enzymes or other residues in 
enzymes of the family. This serine, located in the middle of the loop 
and mutated to proline was expected to affect loop flexibility. In 
result of the S371P mutation, we observed strong decrease of the 
activity. Similar mutation was described in an allele of another 
member of the family, phosphatidylglycerophosphate synthase from 
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E. coli (Usui et al., 1994). The corresponding Thr60 was also mutated 
to proline resulting in lower enzyme activity and causing acidic-
phospholipid deficiency.  
Interestingly, the loop (interconnecting TM2-TM3) comprises three 
lysine residues Lys269, Lys372 and Lys373. Positively charged 
residues and flexibility may suggest a role of the loop in attracting the 
negatively charged substrates from solution and maybe the initial 
binding of substrates before passing to the deeper location of the 
active site binding pocket.  In addition to the positively charged loop 
at the entrance to the putative active site, there is also Arg365, part of 
the conserved sequence pattern. Similarly, its role might involve 
attracting substrates from solution and positioning the substrate in 
the active site. We found that its positive charge is important for the 
activity and its mutation to methionine resulted in strong reduction 
of activity.  
Ala364 is also part of the CSP and is located next to Arg365, and 
roughly beneath the loop between TM2 and TM3. Its short side chain 
may enable more mobility for the loop or even provide space useful 
for transient binding of the substrate by the flexible loop, and hence 
mutant A364M was found to strongly reduce the enzyme activity.  
The bottom of the hydrophilic cavity inside the DIPPS domain is 
formed by three strictly conserved arginine residues, Arg383, Arg443 
and Arg446. The last two are anchored in place by the strictly 
conserved Asp386, which indicate that positions of those arginines 
may be important. In fact, mutation of R443A inactivates the enzyme. 
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Arg443 is only 4.4 Å away from Asp382 (important for catalysis), and 
3.2 Å away from Asp357 (H-bonding to hydroxyl on C3 of docked L-
myo-inositol 1-phosphate, which is involved in reaction). It is 
proposed that Arg443 provides the binding site for the β phosphate 
of CDP-L-myo-inositol, which is involved in the reaction to give the 
final adduct with L-myo-inositol 1-phosphate.  
Mutagenesis of residues from the CSP to alanine or glycine was 
previously described for Saccharomyces cerevisiae 
cholinephosphotransferase (CPT1) (Williams and McMaster, 1998). 
The striking difference in the obtained results concerns the first 
residue of the CSP, the counterpart of Asp360 (residue D113 of 
CPT1). In DIPPS, both mutations to alanine and asparagine inactivate 
the enzyme, while in CPT1 has almost no effect on its activity. This 
could indicate that Asp360 has a more specific role for the type of 
substrate. An alternative explanation could be that the high 
temperature (85˚C) at which the activity tests are performed may 
require stronger binding of Mg2+ in order to keep it in the active site 
for reaction. Mutations to alanine of the other two aspartates 
corresponding to Asp378, Asp382 (Asp131, Asp135 of CPT1) 
inactivate both enzymes.   
DIPPS mutations A364M, R365M and mutations of corresponding 
residues of CPT1 (Ala117, Arg118) to glycine and alanine 
respectively, reduced strongly the activity in all the cases. While 
mutation of Ala364 to methionine imposes additional steric 
hindrance, its mutation to glycine must influence the reaction in a 
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different way. Possibly, by destabilizing the secondary structure at 
the top of the TM2 and thus displacing the Arg365.  
In our study the conserved glycine residues were not tested, however 
very interesting results were obtained for CPT1. The counterpart of 
Gly361 (Gly114 in CPT1) mutated to alanine abolished enzyme 
activity. This glycine is positioned next to the first aspartate of the 
consensus pattern and one helix turn above is located the arginine of 
consensus pattern. Alanine side chain introduces small additional 
space restriction and also limits the flexibility of the helix backbone. 
The inactivating effect of this mutation may indicate that in the 
course of reaction there is some significant conformational change 
required, which is dependent on the presence of the conserved 
glycine.   
Mutation to alanine of another glycine (Gly127 in CPT1, 
corresponding to Gly374 of DIPPS) of the CSP also abolished activity 
underlining the crucial role of the flexible loop between TM2 and 
TM3. 
Detailed analysis of the enzyme mechanism and function of 
particular residues is at this stage impaired by lack of experimental 
information on the substrates binding mode. It was possible to dock 
L-myo-inositol 1-phosphate (Figure 3.18) into the well conserved 
pocket of DIPPS domain. However, reasonable positioning of the 
second substrate appears to be more troublesome.  
The CDP-alcohol phosphatidyltransferase family of enzymes perform 
the same type of reaction thus may utilize common catalytic residues. 
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Moreover, one of the substrates is activated for reaction by coupling 
with CDP. This implies that some of the family consensus pattern 
residues may be involved in forming the binding site of the CDP 
fragment. 
In the first approach it would be reasonable to assume binding of the 
CDP fragment to a site within the loop between TM2 and TM3, and 
upper part of those helices where the CSP residues are located. 
However, the apparent flexibility of the loop may result in adopting 
the proper conformation of polypeptide for substrate binding only in 
the presence of the substrate. 
If that is indeed the case and CDP binds in the loop, then possibly the 
β phosphate of CDP could coordinate to Mg2+, to be activated for the 
nucleophilic attack by the hydroxyl of the L-myo-inositol 1-
phosphate, as the likely mechanism relies on a single displacement 
reaction (Raetz et al., 1987). That will leave relatively large opening in 
the center of DIPPS domain just for inositol fragment. Thus an 
alternative binding position of the CDP fragment of substrate is in the 
bottom of the active site opening, which is formed by three conserved 
arginine residues (one of them mutated to alanine inactivated DIPPS). 
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CONCLUSIONS 
 
Herein, we present the first structure of CDP-alcohol 
phosphatidyltransferase family representative, CDP-L-myo-inositol 
myo-inositolphosphotransferase (DIPPS). It is fused with L-myo-
inositol 1-phosphate cytidylyltransferase (IPCT) domain, which 
activates the L-myo-inositol 1-phosphate for the second 
phosphotransfer reaction. The IPCT domain displays the typical 
features of the nucleotidyltransferases with extended Rossmann fold 
pattern. The DIPPS domain is integral to the membrane, with 6 
transmembrane helices and one amphipathic helix positioned 
approximately parallel to the membrane surface. The helices form 
approximately 20 Å deep hydrophilic opening in the domain, which 
contains residues of the conserved sequence pattern of CDP-alcohol 
phosphatidyltransferase family and putative Mg2+ binding site. The 
dimeric quaternary arrangement is formed through an extensive 
interface involving three of the transmembrane helices. The IPCT 
binds weakly to the solvent exposed edge of DIPPS domain in an 
arrangement in which the two active sites do not face each other. 
In an attempt to shed light on the location and the role of active site 
residues, L-myo-inositol 1-phosphate was docked into the DIPPS 
domain and mutagenesis studies allowed identification of several 
residues important for DIPPS activity.  
DIPPS is a member of the CDP-alcohol phosphatidyltransferase 
family, for which no structure was yet available. This family 
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comprises integral membrane proteins, such as choline/ethanolamine 
phosphotransferase and cardiolipin synthase. Members of this family 
are present in all domains of life and usually involved in 
phospholipid biosynthesis. The X-ray structure of IPCT/DIPPS 
determined at 2.8 Å resolution will have a significant impact in the 
field of lipid biosynthesis and will pave the way to further studies, 
for example, exploring the mechanism of reaction, homology 
modeling followed by structure-based drug design. 
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This thesis describes the protein production and structures of two 
new enzymes; a bifunctional CTP:L-myo-inositol 1-phosphate 
cytidylyltransferase (IPCT) and CDP-L-myo-inositol myo-
inositolphosphotransferase (DIPPS) from Archaeoglobus fulgidus at 2.8 
Å resolution, and an α-phosphoglucomutase from Lactococcus lactis at 
1.5 Å resolution.  
The IPCT/DIPPS was a challenging target to study as its DIPPS 
domain is integral to the membrane. Membrane embedded 
hydrophobic helices contribute to a number of obstacles in protein 
production and crystallization, which explains the very limited 
number of membrane protein structures available to date. In 
particular, the crystal diffraction quality varies significantly within 
the same crystallization conditions and thus numerous crystals need 
to be screened for diffraction, with considerable synchrotron 
beamtime required. In a collaborative effort these problems were 
overcome and the first structural insights into the CDP-alcohol 
phosphatidyltransferase family have been achieved. The novel DIPPS 
structure contains six transmembrane helices, unlike all the 
attempted sequence-based transmembrane region predictions (2 - 5 
TMs). It reveals a hydrophilic cavity with active site residues in the 
central part of the domain and opens to the cytoplasm. Crucial 
residues for the enzyme activity have been identified by mutagenesis 
studies and docking of L-myo-inositol 1-phosphate provided 
preliminary insights into the substrate binding mode. Further studies 
will follow to provide structural information on the enzyme 
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complexes with its substrates. That in turn will facilitate exciting 
studies involving mutagenesis and computer modeling aiming at the 
detailed description of reaction mechanism with impact on the fields 
of compatible solute and lipid biosynthesis. Interesting new 
opportunity also opens for computational modeling studies, which 
now can provide homology models for some relevant related 
proteins. 
A study that can be facilitated by the available structure concerns 
IPCT/DIPPS activation at temperatures over 60˚C, with maximum 
activity at supraoptimal temperatures for (hyper)thermophiles. The 
related lipid-biosynthesizing enzymes from mesophilic organisms do 
not require elevated temperatures for catalysis of the same type of 
reaction. This points to a possibility of temperature induced 
mechanism for enzyme activation, which might be probed in a search 
of structural changes e.g. by NMR.  
Another open question concerns the possible cooperation between 
the two domains with consecutive activities, IPCT and DIPPS, of 
which active sites in the obtained structure face apart from each 
other.  
It is worth mentioning that the majority of CDP-alcohol 
phosphatidyltransferase family members comprise a single integral 
membrane domain. This might have been a disadvantage in the 
crystallization trials thus far. In this study, the bifunctional 
IPCT/DIPPS construct proved to be crucial in the crystallization as the 
crystal contacts were formed mainly through the cytoplasmic IPCT 
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domain. This result may indicate the direction worth exploring in 
structural studies of other members of CDP-alcohol 
phosphatidyltransferase family.  
 
The novelty of the second structure described in this thesis, α-
phosphoglucomutase from Lactococcus lactis (APGM), is in its 
substrate specificity. It is the first structurally characterized bacterial 
α-phosphoglucomutase with structure unlike the common α-
phosphoglucomutases of α-D-phosphohexomutase superfamily. 
Based on the sequence similarity, conservation of the catalytic 
residues and in particular the structural similarity, APGM may be 
regarded as eukaryotic phosphomannomutase (PMM), which lost its 
ability to utilize mannose 1-phosphate. In this context the modeled α-
glucose 1-phosphate in the active site compared with the structures of 
PMMs provided very interesting clues regarding the substrate 
discrimination. This lead to a proposal that single residue changes at 
the otherwise conserved substrate binding site may be responsible for 
the differentiation between the two epimeric compounds, mannose 1-
phosphate and α-glucose 1-phosphate of APGM. The obvious next 
step should include mutagenesis study to assay if with single 
mutations the APGM activity towards mannose 1-phosphate could be 
observed. 
Other interesting experiments that could be performed concern the 
quaternary structure of APGM, which in the crystal structure appears 
to form a novel dimeric assembly as compared to other eukaryotic 
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PMMs. Mutagenesis on the putative dimeric interface could be used 
in an attempt to disrupt the observed dimer in solution. Moreover, 
upon dimer formation in the center between the two active sites a 
patch of positive charge is observed and mutagenesis could give 
information if this charge provides some advantage with regards to 
the enzymatic efficiency.   
X-ray crystallography provides invaluable information on the atomic 
details of biological macromolecules with two new structures being 
described here. It is the structural biologist task to interpret those 
protein models and find clues regarding their relevance for the 
protein function. This task has been developed in this work and 
resulted in a number of new questions, which still need to be 
addressed with further crystallographic and biochemical studies. The 
efforts to better understand the structure-function relation of proteins 
described here will be continued in our Laboratory, so one can 
anticipate further exciting results emerging from the work developed 
in the course of this thesis. 
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Appendix 1 Sequence alignment of proteins with IPCT/DIPPS activity.  
Created with Geneious alignment (Geneious 6.0.3 software) based on IPCT and DIPPS 
sequences from 33 organisms with confirmed or putative DIP production (Gonçalves et al., 
2012). The colored bar above alignment indicates conservation of the residues and from 
green for strict conservation and red no conservation. Additionally, the residue symbols are 
in black boxes for strictly conserved to grey for similar residues. The 1st sequence is a gene 
annotated as IPCT/DIPPS of Archaeoglobus fulgidus and the 2nd sequence is the construct 
described in this study and expressed with additional tags for purification. 
UniProt codes of the sequences: O29976_ARCFU (Archaeoglobus fulgidus), E0SRX5_IGNAA 
(Ignisphaera aggregans), B1L3B5_KORCO (Korarchaeum cryptofilum), E4M3F3_9FIRM 
(Thermaerobacter subterraneus), E6SL49_THEM7 (Thermaerobacter marianensis), 
Q1AWQ0_RUBXD (Rubrobacter xylanophilus), B7R372_9EURY (Thermococcus sp. AM4), 
Q5JDA9_PYRKO (Pyrococcus kodakaraensis), B6YXC3_THEON (Thermococcus onnurineus), 
D1CEN7_THET1 (Thermobaculum terrenum), F0LMX7_THEBM (Thermococcus barophilus), 
F8A8W4_THEID (Thermodesulfatator indicus), O67379_AQUAE (Aquifex aeolicus), 
Q9UZW1_PYRAB (Pyrococcus abyssi), A8UUK0_9AQUI (Hydrogenivirga sp. 128-5-R1-1), 
C5A1T6_THEGJ (Thermococcus gammatolerans), O58964_PYRHO (Pyrococcus horikoshii), 
D2RHQ4_ARCPA (Archaeoglobus profundus), D5VRC1_METIM (Methanocaldococcus 
infernus), C6A371_THESM (Thermococcus sibiricus), D3S199_FERPA (Ferroglobus placidus), 
F2KS67_ARCVS (Archaeoglobus veneficus), I6TWS7_9EURY (Pyrococcus furiosus COM1), 
C0QSN6_PERMH (Persephonella marina), G0EE02_PYRF1 G0EE03_PYRF1 (Pyrolobus 
fumarii), Q9YBT3_AERPE (Aeropyrum pernix), A2BJ61_HYPBU A2BJ62_HYPBU 
(Hyperthermus butylicus), A5IMG5_THEP1 A5IMG6_THEP1 (Thermotoga petrophila), 
B1LBF8_THESQ B1LBF7_THESQ (Thermotoga sp), B9K8G7_THENN B9K8G8_THENN 
(Thermotoga neapolitana), D2C420_THENR D2C421_THENR (Thermotoga naphthophila), 
G4FFF3 G4FFF4 (Thermotoga maritime). 
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Appendix 2 Enzymatic assays of IPCT/DIPPS mutants. The IPCT/DIPPS activities were 
assessed in cell extracts of E. coli C43, harboring wild-type or mutant variants of the 
ipct/dipps gene from A. fulgidus. The cell pellets were suspended in 50 mM Bis/Tris/Propane-
HCl (pH 8.0) containing 5% glycerol and 100 mM NaCl; cells were disrupted in a French 
press and debris removed by centrifugation (10,000g, 15 min, 4C). Reaction mixtures (0.3 ml) 
containing 25 mM Bis/Tris/Propane-HCl (pH 8.0), 10 mM MgCl2, 2.7 mM CTP, 7 mM myo-
inositol-1-phosphate, and cell extract (0.9 mg of total protein) were incubated at 85°C for 30 
min. The reactions were stopped on ice prior to the addition of deuterated water (200 l) and 
25 mM EDTA (pH 8.0). The reaction products of IPCT and DIPPS, i.e., CDP-myo-inositol and 
DIPP, respectively, were quantified by 31P-NMR using diglycerol-phosphate as an internal 
concentration standard.  
 
IPCT/DIPPS mutation DIPP [mM] % 
   
WT IPCT/DIPPS 4.83 100 
   
S308A 1.65 34.2 
   
S308M 
 
0.00 
0 
   
D357A 0.00 0 
   
D357N 0.21 4.3 
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D360A 0.00 0 
   
D360N 0.00 0 
   
A364M 0.29 6.0 
   
R365M 0.59 12.2 
   
S371P 0.26 5.4 
   
D378A 0.00 0 
   
D378N 0.00 0 
   
D382A 0.00 0 
   
D382N 0.00 0 
   
R443A 0.00 0 
   
WT (no Mg2+) 0.00 0 
 
  
 
Appendix 3 Monodispersity tests of IPCT/DIPPS in the presence of different detergents.
samples were incubated for 6 days at 20˚C with tested detergent at about two times of its 
critical micelle concentration. Sample was analyzed by size exclusion chromatography 
(Superdex 200 5/150 GL). The detergents names abbreviations used: DDM 
maltoside,  DM - n-Decyl β-D-maltoside, LDAO 
5-Cyclohexyl-1-Pentyl-β-D-Maltoside, NG - n-
β-D-Thioglucopyranoside, OG - n-Octyl-β-D-
Propyl-β-D-Maltoside, MEGA-8 - Octanoyl
Cholamidopropyl)dimethylammonio]-1-propanesul
Cholamidopropyl)dimethylammonio]-2-Hydroxy
Cyclohexylpropanoyl-N-Hydroxyethylglucamide, HEGA
Hydroxyethylglucamide, C-HEGA-8 - Cyclohexylethanoyl
- n-Decyl-β-D-Thiomaltopyranoside, Cymal-4 
n-Octyl-β-D-Thiomaltoside, Fos-Choline-10 - 
Nonylphosphocholine, Fos-Choline-8 - n
Octaethylene Glycol Ether, ZWITTERGENT 3
propanesulfonate, DDAO - Decyldimethylamine N
N,N-dimethyl-3-ammonio-1-propanesulfonate, 
Hydroxyethylglucamide, C8E5 - N-Octylpentaoxyethylene, 
Thioglucopyranoside, HTG - n-Heptyl-β-D-Thioglucopyranoside
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 The 
- n-Dodecyl β-D-
- Lauryldimethylamine-N-Oxide, Cymal-5 - 
Nonyl-β-D-Glucopyranoside, OTG - n-Octyl-
Glucopyranoside, Cymal-3 - 3-Cyclohexyl-1-
-N-methylglucamide, CHAPS - 3-[(3-
fonate, CHAPSO - 3-[(3-
-1-Propanesulfonate, C-HEGA-9 - 
-8 - Octanoyl-N-
-N-Hydroxyethylglucamide, DTM 
- 4-Cyclohexyl-1-Butyl-β-D-Maltoside, OTM - 
n-Decylphosphocholine, Fos-Choline-9 - n-
-Octylphosphocholine, C12E8 - Dodecyl 
-12 - n-Dodecyl-N,N-dimethyl-3-ammonio-1-
-oxide, ZWITTERGENT 3-10 - n-Decyl-
HEGA-10 - Decanoyl-N-
NTG - n-Nonyl-β-D-
. 
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